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ABSTRACT
The Development of a Short Form of the Clinically Adaptive Multidimensional Outcome Survey
Peter William Sanders
Department of Counseling Psychology and Special Education, BYU
Doctor of Philosophy
The Evidence-Based Practice (EBP) movement has gained considerable influence in the
healthcare industry, including psychotherapy. The American Psychological Association’s (APA)
official stance on EBP encouraged clinicians to used standardized outcome measures in routine
practice in order to establish the efficacy of their interventions. Routine Outcome Measurement
(ROM) systems were designed specifically to accomplish this purpose, and have been shown to
improve client outcomes and provide valuable aggregate data that contributes to empirical
literature. Despite this research and the endorsement of the APA’s official EBP stance, these
measures have not been widely adopted by clinicians. Several studies have found that clinicians
find the measures impractical and lacking in clinical relevance.
In order to accommodate these clinician concerns, while still maintaining the major
features of ROM, the Clinically Adaptive Multidimensional Outcome Survey (CAMOS) was
developed. The CAMOS employs a unique system that allows clinicians to be able to tailor the
measure to the needs of their client, while still maintaining a core of standardized items. The
present study attempted to identify a short form of McBride’s measurement model, in order to
determine which items would form this standardized core. The study found evidence for the
validity and reliability of the CAMOS short form. With this evidence, the short form can serve
as the basis for the CAMOS’s unique tailoring system. It is hoped that the novel features of the
CAMOS can help accomplish the APA’s goals in relation to EBP.
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DESCRIPTION OF DISSERTATION STRUCTURE AND CONTENT
This dissertation, The Development of a Short Form of the Clinically Adaptive
Multidimensional Outcome Survey, is written in a hybrid format. This hybrid format integrates
traditional dissertation requirements and journal publication formats. The initial pages of this
dissertation are for the purpose of fulfilling requirements for submission to the university. The
remainder of the dissertation is written in a format that will allow it to be converted for a journal
submission. The review of the literature is included in the Appendix. There are two reference
lists contained in this dissertation. The first reference list contains references included in the
journal-ready article. The second reference list includes all the references for the review of the
literature.

1
Introduction
In the early 1990’s a movement called Evidence-Based Practice (EBP) began to gain
considerable influence in the field of applied psychology (Walker & London, 2007). The central
tenet of EBP was that clinical work should be directly tied to scientific findings in order to
ensure that practitioners were using interventions that had documented efficacy, were of high
quality, and were cost-effective (Bower & Gilbody, 2010; Levant & Hasan, 2008; Spring, 2007).
In 2005, the American Psychological Association (APA) assembled a presidential task force in
order to formulate an official organizational stance on the issue of EBP. The result of this task
force’s work was a policy known as Evidence-Based Practice in Psychology (EBPP; APA
Presidential Task Force on Evidence-Based Practice, 2006). This report differed from previous
EBP policies, such as APA Division 12’s Empirically-Supported Treatments (EST), in that the
identification of specific treatments for specific disorders was de-emphasized in favor of general
principles of evidence-based decision-making (Chambless et al., 1998; Levant & Hasan, 2008;
Task Force on Promotion and Dissemination of Psychological Procedures, 1995). This policy
provided a bottom-up approach to EBP, in which clinicians would be able to creatively tailor
their treatment approaches while still practicing EBP if they were incorporating the decisionmaking principles espoused in the report. (Wampold, Goodheart, & Levant, 2007).
In moving away from creating lists of specific treatments for specific disorders, a new
way to ensure accountability would need to be determined (Wampold et al., 2007). The EBPP
task force’s solution was to use systems that enabled “ongoing monitoring of patient progress
and adjustment of treatment as needed” and stated that these systems “are essential to EBPP”
(APA Presidential Task Force on Evidence-Based Practice, 2006, p.280). This would provide
evidence for the work that the clinicians were doing with the actual clients they were seeing,

2
instead of relying on treatments validated in another treatment center. As of the time of the
EBPP report, several measures already existed that were designed for these specific purposes
(Stuart & Lilienfield, 2007). These measures are part of a growing paradigm known as Routine
Outcome Monitoring (ROM; Carlier et al., 2012; Trauer, 2010a).
Routine Outcome Monitoring
ROM involves the use of standardized instruments that are designed to be practical,
relevant, and rigorous in assessing patient progress throughout the course of therapy in
naturalistic settings (Goodman, McKay, & DePhilippis, 2013). In order to reliably assess
relevant variables in as few items as possible, ROM systems generally use a global measurement
approach (Lambert, Okiishi, Finch, & Johnson, 1998). From a global measurement perspective,
optimal items are those that are applicable in most contexts, with items that are applicable only
to specific populations, theories, or clients being excluded (Lambert et al., 1996; Ogles, Lambert,
& Masters, 1996). A key component of global assessments is the necessity of establishing the
psychometric properties of the measure, in order to ensure that the meaning of the items is
standardized (Ogles, Lambert, & Fields, 2002; Tarescavage & Ben-Porath, 2014). Several ROM
systems have demonstrated strong reliability and validity with relatively few items, which ROM
proponents view as evidence that the measure is generally capturing the primary relevant
phenomena of interest to clinicians, even if it is not capturing everything (Boswell, Kraus,
Miller, & Lambert, 2015; Tarescavage & Ben-Porath, 2014).
This measurement approach provides the basis for several features that allow ROM
systems to be suitable for aggregate data analysis as well as to aid in the treatment of individual
clients (Carlier et al., 2012). At the aggregate level, ROM can provide a relatively un-intrusive
means of gathering quality data that could be used in research or program evaluation to provide
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evidence that groups of clients are benefitting from treatment (Trauer, 2010b). At the level of
the individual client, ROM systems provide real-time feedback that allows clinicians to track a
client’s progress across the course of therapy and to compare that client’s improvement with
either rationally or statistically-derived expected treatment response (ETR) curves (Beutler,
2001; Lueger, et al., 2001). This has been shown to improve treatment outcomes and contain
costs, especially for clients who are at risk of treatment failure (Carlier et al., 2012; Goodman et
al., 2013; Lambert et al., 2003; Shimokawa, Lambert, & Smart, 2010). With these features,
ROM appears to be an ideal solution for facilitating Evidence-Based Practice in routine
treatment without the need for top-down prescriptive guidelines (Wampold et al., 2007).
Obstacles to Implementation
Despite the endorsement of the EBPP task force, as well as nearly two decades of
empirical research documenting its benefits, ROM has not been widely adopted by clinicians
(Bickman et al., 2000; Gilbody, House, & Sheldon, 2002; Goodman et al., 2013; Hatfield &
Ogles, 2004; Hatfield & Ogles, 2007). Some studies have found that even among clinicians that
do routinely assess outcomes, only a small percentage actually use the real-time feedback
provided by the measures (Garland, Kruse, & Aarons, 2003; Trauer, 2010b). For ROM to fulfill
its role in achieving the objectives of EBPP, it is essential that it be more widely adopted, and
that where adopted, the feedback be used to improve the quality of care. In order to increase the
implementation and usage of ROM, it is necessary to understand some of the possible reasons
that clinicians have not adopted it as well as discuss some of the ways that ROM developers have
attempted to deal with these concerns.
Relevance and practicality. Two of the primary reasons for a lack of clinician usage of
ROM identified in the literature are that they are perceived as not relevant or impractical
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(Abrahamson, 1999; Trauer, 2010b). This is often surprising to ROM developers given that, as
discussed above, they have developed brief assessments with good psychometric properties
(Boswell et al., 2015). The use of global items to assess outcomes, however, comes at the
expense of assessing aspects of the therapeutic encounter that are context-specific, that
psychotherapists and patients may consider important (Evans 2012, Lakeman, 2004). In contrast
to ROM developers’ assumption that psychometric reliability and validity are sufficient for a
measure to be relevant to clinical needs, several studies have found that practitioners often do not
view standardized global items as possessing high clinical utility, and often place higher value on
population-specific and individualized outcomes (Ashworth et al., 2007; Happell, 2008; Meehan,
McCombes, Hatzipetrou, & Catchpoole, 2006). If practitioners place high value on these
context-specific outcomes, which are purposely excluded from ROMs, it would come as little
surprise that they would not see great value in adopting these systems. Clinicians would
essentially be tracking their clients’ progress and having their work evaluated based on criteria
that they do not view as germane to treatment.
There is some evidence that these clinicians’ concerns may not be unfounded, with
Ashworth and colleagues (2007) finding that the CORE-OM (a prominent ROM system) did not
address 60% of the topics that brought clients into therapy in a relatively large sample of clients.
From this perspective, although a broad approach to measurement may allow for brevity, it could
be argued that any time spent on a measure that is not assessing what is most important to
treatment is “too much” time. If this is the case, then even a brief global measure could be both
irrelevant and impractical because it is not providing enough useful information to justify the
time and money spent. Additionally, some have expressed concern that a focus on the outcomes
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included in ROM may lead practitioners to decrease their attention to other areas of concern that
are not included in the instrument (Browne, 2006; Evans, 2012; Lakeman, 2004).
On the other hand, a major limitation of more individualized approaches to outcome
measurement (i.e., Target Problems or Goal Attunement Scaling) is that they are more difficult
to compare across clients, thus making it difficult, if not impossible, to aggregate data across
clients or to create ETR curves (Lambert et al., 1998; Ogles, et al., 1996). If this were the case,
the major benefits of ROM would be lost. This puts researchers and clinicians at an impasse:
Both want the assessments to be brief, but ROM developers place high priority on
standardization, aggregation, and comparability, while many clinicians value assessments that
are specific to the populations they work with, their theoretical approach, and the unique
circumstances of their clients (Sales & Alves, 2012).
Implementation approaches. In attempting to implement ROM systems, researchers
have often conceptualized clinician concerns about relevance as obstacles or barriers that need to
be overcome (Meehan, et al., 2006; Walfish, McAlister, O'Donnel, & Lambert 2012;). In order
to overcome these barriers, ROM developers have attempted to change what they perceive to be
erroneous clinicians’ attitudes (Abrahamson, 1999; Hannan et al. 2005; Meehan, et al., 2006).
The lack of usage of ROM suggests that clinicians have generally not changed their attitudes,
which has led many ROM proponents to lament clinician resistance toward measures that have
documented efficacy in improving outcomes (Boswell et al., 2015; Tascaverage & Ben-Porath,
2013; Walfish et al., 2012;).
This lack of adoption is unsurprising in light of a growing literature in the field of
organizational behavior that has begun to question the validity and utility of conceptualizing
organizational change as a process of overcoming barriers or obstacles from “resistant” change
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recipients (Ford, Ford, & D’Amelio, 2008; Thomas & Hardy, 2011). In regards to the efficacy
of approaches that attempt to minimize “resistance”, Thomas & Hardy (2011) stated: “While
change can be imposed, it is more likely to be taken on by members of the organization if they
have played a part in the negotiations of new meanings, practices and relationships” (p.323).
From this perspective, implementation would be more likely to be successful if ROM developers
allowed treatment sites to have input about the measures. In existing ROM systems, however,
only minor logistical concerns such as the frequency or format (digital or paper) of
administration are negotiable, but tailoring the content of the measure itself to the unique needs
of a treatment site is typically not offered as an option (Boswell et al., 2015; Mellor-Clark, Cross,
Macdonald, & Skjulsvik, 2014).
The approach to development that undergirds existing ROM systems does not allow for
the flexibility necessary for an implementation approach in line with Thomas & Hardy’s (2011)
views. Clinicians cannot negotiate the outcomes that will be assessed in the measure, because in
the current paradigm of ROM development, such adaptations are difficult, if not impossible, to
accommodate (Boswell et al., 2015). The primary reason for this lack of flexibility is the
assumption that for an item or dimension to be useful, it must be psychometrically validated and
that if validated, the measure is sufficiently relevant to generate locally applicable data (Lambert
et al., 1998; Slade, 2002). This validation process can be very time, labor, and resource
intensive, often involving years of work across thousands of participants (Kraus, Seligman, &
Jordan, 2005). If, however, this assumption is invalid and clinicians are correct that the
measures lack relevance for their specific contexts, then ROMs offer little of value. What use is
an ETR for outcomes that are not relevant to treatment, or how useful are outcome studies based
on data that is not reflective of the true goals of therapy? Thus, in the current paradigm, ROM
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developers have little option but to view clinician non-adoption as resistance, because their
systems were not designed to facilitate negotations about local meanings of outcome, and the
utility of their instruments are threatened by clinician feedback.
The Clinically Adaptive Multidimensional Outcome Survey
In order to both maintain the current benefits of ROM as well as allow clinicians to have
a voice in defining the meaning of outcome, a new paradigm for ROM development is necessary.
With these considerations in mind, the Clinically Adaptive Multidimensional Outcome Survey
(CAMOS) was designed. Contrary to existing ROM systems, the CAMOS does not make the
assumption that only standardized or global items are of clinical value, nor that psychometric
validation is sufficient for a measure to be of clinicial relevance. Thus, in addition to having a
core of standardized items similar to existing ROM systems, the CAMOS allows all stakeholders
involved in the therapeutic process to have input in defining which concerns and constructs will
be assessed in the measure. This flexibility allows the CAMOS to be relevant to specific
contexts, not because the developers are assessing every possible outcome, but because the major
stakeholders in treatment can adapt it to specific treatment contexts. This system changes the
agenda of implementation from one of attempting to change clinician attitudes in order to fit the
measure, to making the measure change to fit local needs.
The clinically adaptive method. One major concern with this tailoring is that it may
create an excessive time burden for clients and therapists, which could be a significant barrier to
adoption of the measure (Duncan, 2012). This has been shown to be the case with systems that
have attempted to combine standardized and individualized approaches to treatement (Sales &
Alves, 2012). Thus, in order to accomplish the goal of adapting to the contextual needs of
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clinicians, while still maintaining the main features of ROM, the tailoring process must be more
feasible than existing systems.
The CAMOS’s unique approach is called “Clinically Adaptive” assessment and involves
making a small subset of items required for all administrations, while allowing other items to be
optional. These optional items can then be added or removed from the CAMOS at the discretion
of the treatment site or individual therapist. Required items are standardized in the same way as
traditional ROMs, and allow for aggregation and comparability, thus maintaining the major
features of these systems. The optional items can either be chosen from an existing pool of items
(the item pool will be discussed in depth below) or can be written by the treatment site and/or
therapist. This tailoring can occur at three levels: (a) items or dimensions can be added,
excluded, or created that will display only on the CAMOS survey of all clients at a specific
treatment site, (b) items can be added or authored that appear only on the CAMOS survey of
clients assigned to a specific therapist (c) items can be added or authored that are displayed only
to individual clients. This multi-level tailoring approach differs from idiographic approaches
which primarily allow for tailoring at the level of the individual client (Sales & Alves, 2012).
The clinically-adaptive method allows for the creation of a template that incorporates the
views of various stakeholders, while still allowing for individualized tailoring. Additionally, the
option to add items or dimensions based on an existing pool, instead of relying exlusively on
clients or therapists to author new items for each client, allows the tailoring process to be much
more efficient. At the site and therapist level, pilot testing has found that this tailoring process
only requires a one-time 5-10 minute investment for therapists, substantially reducing time
burden relative to idiographic approaches, and allowing for needs at various levels to be
accommodated, while still allowing for comparability. At the level of the individual client, items
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can be easily added or removed from the survey at any session by simply checking a box in the
client’s report. As discussed above, if the clinician or treatment site would like to invest more
time to author items, the option is available. Additionally, if a clinician is content to use the
CAMOS as a traditional ROM, they can use it with no tailoring involved.
This tailoring is made possible through modern computational developments and would
be impossible to perform with standard pen-and-paper surveys. The use of this technology also
allows for the survey to retain data obtained about the client, as well as input from the therapist,
in order to generate a customized survey that is relevant to the needs of the client and the
orientation of the therapist. The use of computers to administer the measure also makes possible
automated scoring and the generation of real-time reports, thus saving valuable clinician time
(Boswell et al., 2015). Finally, this facilitates more accurate and feasible data analysis for
researchers examining the data, while obviating the need for data entry, which can be time
consuming and introduces the potential for human error in creating the data set.
CAMOS item development. The full form of the CAMOS item pool was developed
based on Richards and Bergin’s (2005) multilevel assessment approach as well as
recommendations from the ROM literature (Slade, 2002). Richards and Bergin proposed
measuring distress in seven dimensions: cognitive, emotional, relational, physical, behavioral,
spiritual, and occupational. In addition to these dimensions, a therapy progress dimension was
added to evaluate client perceptions of the therapeutic alliance. Items were developed by the
CAMOS research team in order to assess these 8 domains of functioning. On each CAMOS
item, the client is asked to report the level of distress they experienced over the past week on a 6point likert scale (Never, Rarely, Sometimes, Frequently, Almost Always, Always). These items
were then evaluated by clinicians at multiple treatment sites and were adjusted after several
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iterations of feedback to create an initial pool of 72 items. The full item pool was administered
at two treatment sites, and McBride (2015) performed exploratory and confirmatory factor
analysis on this data. His analysis led to a 45-item 6 factor model that left the majority of the
theoretical dimensions intact, but collapsed the behavioral, emotional, and cognitive dimensions
into one factor called psychological distress.
The Need For a Short Form
McBride’s model was designed primarily to define the items that would be required at the
initial intake assessment, making all others optional. Its focus was to identify a wide variety of
potential client concerns. This model, however, was not intended to be administered on a
session-by-session basis while still allowing for tailoring. Most ROM systems are designed to be
brief in order to allow session by session administration, with most being composed of less than
50 items. Given that the full form is composed of 42 items, this leaves little to no room for
clinician tailoring, without making the assessment excessively burdensome. The present study
aims to create a short form of the CAMOS that will serve as the required items for session-bysession measurement, with all items not included in the short form becoming optional after the
first session. Thus, the items identified in the short form will not vary from session to sesson.
This form will need to be sufficiently brief in order to allow for additional site, therapist, and
client level adaption. If this short form proves to have adequate psychometric properties, it
would provide a standardized core for the CAMOS that is useful for aggregate data analysis
which would allow for the development of ETR curves, while still being responsive to the voice
of the clinician and client.
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Method
Participants
Sample 1. The sample consisted of 304 participants in treatment at a private university
counseling center in the western United States with a wide variety of diagnoses. Therapists
assigned diagnoses to 215 (71%) clients, of which, 118 (54%) were given at least two diagnoses.
The most frequent diagnoses were major depression (n = 106), anxiety disorders (n = 72), and
impulse control disorder (n = 23). The participants’ ages ranged from 17 to 57 years of age, with
a mean of 21.8. There were 186 (61.2%) female participants and 116 (38.2%) male participants.
The self-identified racial demographics were as follows: 76% White/Caucasian, 8% Latino/a,
2% Asian, 1.0% Native American, 1% African American, .3% Pacific Islander. Twelve percent
of clients did not respond to the racial demographics item. The religious affiliations of the
participants were: 98.7% Latter-Day Saint (LDS), .3% other, and 1 participant did not identify
him/herself with a religion. Participants were recruited for the study by a secretary inviting them
to participate as part of their intake paperwork. This was voluntary for clients entering treatment
and participants could leave the study at any point.
Sample 2. Participants were in treatment at an inpatient eating disorder clinic in the
western United States. The sample was composed of 211 clients, all of whom were female.
Participants’ ranged from 14 - 45 years of age with a mean of approximately 22 years. The
racial demographics of the sample were composed of approximately 80% White/Caucasian, 10%
Latina, 5% African American and 1% Asian and 9% other/multiracial. The religious affiliations
of the sample were approximately 40% Latter-Day Saint, 20% not religious, 20% Protestant
Christian, 10% Jewish and 10% other.
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Procedures
Sample 1. Once the treatment sites had agreed to participate in the study, the developers
of the CAMOS went to the sites in order to integrate the administration of the CAMOS into the
flow of existing office procedures and to train the staff in the usage of the system. This involved
providing the treatment site with Amazon Kindle Fire tablets, setting up links to the survey on
each device, training secretaries and medical technicians in how to access the survey, and
working out other minor logistical issues. The developers also met with the clinicians to
demonstrate how the system would work, as well as to get feedback about the items. The
feedback was then incorporated into the CAMOS.
Upon making an appointment for their first session, clients were invited to participate in
the study and signed an informed consent document. They were then entered into the CAMOS
system by having secretaries fill out a brief survey with the client’s identification number and the
identification number of the therapist to which they were assigned. Client and therapist names
were not used in order to ensure confidentiality. When a client came in for her first visit, the
secretary handed him/her the tablet on which he/she would take the survey. In order to ensure
that participants did not make errors in entering their ID numbers, a verification system was
implemented that would only allow participants to take the survey if their ID number was
entered correctly.
After successful login, the client completed the survey. At intake, demographic items
were presented to clients as well as the full CAMOS item pool, allowing for a cross-sectional
data analysis of the full item pool. Following intake, participants only responded to the items in
the areas where they expressed concern on initial screening items. Only intake data were used in
the present analysis. The CAMOS took approximately 5-7 minutes to administer at intake and
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approximately 3-5 minutes to administer in subsequent sessions. After the client had completed
the CAMOS, the clinicians could access a report that provided information about the client’s
responses to individual items, as well as track their scores over time.
Sample 2. Upon being admitted to the treatment center, clients were required to
complete a battery of assessments. With administrative approval, the full initial item pool of the
CAMOS was added to the battery of assessments. The measures were administered via
computer, and clients were directed to take the measures by staff members. The assessments
were not taken at the same time, with the CAMOS being administered separately from other
tests. Given that this assessment procedure was already in place prior to the initiation of the
current study, little training was needed for the CAMOS to be implemented. Additionally, the
authors developed a digital form that allowed staff to see which clients (by ID only, no names
were entered into the system), had completed their assessments. The clients took all items of the
CAMOS at admission as well just prior to their discharge. Only the data from intake
assessments was used in the current study.
Data Analysis
The present analysis imposed more stringent criteria for item retention than were used in
McBride’s analysis, with the intention of shortening the measure to make it more suitable for
repeated measurement in psychotherapeutic settings while still maintaining strong psychometric
properties. The data analysis involved six steps: (1) Removal of highly positively skewed items;
(2) Exploratory Factor Analysis (EFA) on McBride’s full item pool to identify low loading
items; (3) Confirmatory Factor Analysis (CFA) of the model developed through EFA on both
samples (4) Calculation of internal consistency reliability of each dimension; (5) Correlating the
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short form with the corresponding full form of each dimension; (6) Correlating each dimension
with existing measures.
Removal of rarely endorsed items. One of the primary purposes of this study was to
identify items that would be able to track progress across the course of psychotherapy. In order
to do so, the items that were used in the short form would need to leave room for improvement
and be relevant to most clients’ presenting concerns. If items were consistently being answered
at the lower end of the scale (Never or Rarely) at intake, this was interpreted as a floor effect,
and these items may in fact detract from the measure’s sensitivity to change (Kraus, Seligman, &
Jordan, 2005). Thus, items that were endorsed by over 50% of sample 1 as “Never” or “Rarely”
(“Almost Always” or “Always” for positively worded items) at intake were removed from future
analyses. The rationale for this cutoff was that if 50% of clients indicated that the item was of
minimal concern at intake, then by definition, the majority of clients did not find this relevant to
their concerns. This analysis was performed by examining the frequencies of each response using
IBM SPSS 21 statistical software.
Exploratory Factor Analysis. Once these strongly positively skewed items were
removed from the item pool, two Exploratory Factor Analyses (EFA) were performed on the
remaining items. The analyses was performed using the Mplus 7.1 structural equation modeling
software on sample 1 using a Geomin (oblique) rotation, and Weighted Least Squares extraction
(Muthen & Muthen, 2012). The number of factors to retain was determined by Parallel Analysis
(PA), which is considered one of the more precise methods for factor retention decisions
(Hayton, Allen, & Scarpello, 2004; Horn, 1965). In PA, the researcher compares the eigenvalues
generated in the EFA to those of a set of random eigenvalues generated through a Monte Carlo
simulation. Factors are retained that have an eigenvalue that is significantly higher than the

15
random eigenvalue for that factor. In addition to this empirical analysis, a rational examination
of the factors suggested by PA was performed. This is essential in order to determine whether
the factors identified were substantively meaningful and clinically relevant (Fabrigar, 2012).
The first EFA was intended to reduce the item pool by removing items that did not have
substantial loadings onto any factor or that had had high cross-loadings. For this EFA, a
substantial loading was defined as .4 or above, and cross loadings were considered unacceptable
if the difference between the two highest loadings for an item were less than .2. These criteria
helped narrow down the item pool and create more tightly defined constructs by removing items
whose variance was not well explained by any of the factors.
Once this analysis was performed and items were removed according to the criteria
outlined above, an additional EFA was conducted on the remaining items. The rotation,
extraction, and factor retention procedures were identical to the previous EFA. In contrast to the
first EFA, for an item to be included in the final model a loading of .5 or higher on one
dimension was required. The .2 cross loading difference criterion from the previous EFA was
used in this analysis as well. This was done in order to further narrow down the construct to a
small core of items. The minimum number of items for each dimension was put at 4, in order
maximize reliability and construct coverage, while still being relatively brief (Kenny, 1979;
Kline, 2010).
Confirmatory Factor Analysis (CFA). Once a suitable model was generated from the
EFA, a CFA was performed on both samples. CFA allows the researcher to specify an a priori
model that provides a rigorous test of whether the hypothesized model adequately accounts for
the major relationships between the items (Kline, 2010). In contrast to an EFA, CFA involves
fixing all cross-loadings and indicator error covariances to 0 (unless manually overridden by the
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researcher). These stringent constraints provide strong evidence of the validity of the constructs
hypothesized in the model. In order to determine if the model implied covariance matrix
adequately fits the observed data, various fit statistics have been developed (Kline, 2010; Sun,
2005). Mplus 7.1 (the software used for all CFAs in this study) provides the following fit indices
based on the Weighted Least Squares estimator that was used due to the categorical nature of the
items: the Root Mean Square Approximation (RMSEA), the Comparative Fit Index (CFI), the
Tucker-Lewis Index (TLI).
The interpretation of these fit indices, however, has been a topic of debate among CFA
researchers (Marsh, Hau, & Wen, 2004). The most widely used guidelines for interpreting fit
indices were developed by Hu and Bentler (1999). In their study based on Monte Carlo
simulations, the following guidelines were suggested: RMSEA of .06 or below and CFI/TLI of
.95 or above. Hu and Bentler (1999) warned, however, that these should not be used as strict
cutoffs, but general guidelines for model fit. In line with these, and other recommendations (i.e.,
Marsh et al., 2004), the current analysis accepted the model if the fit was near the values
suggested by Hu and Bentler (1999), but gave some flexibility if the exact values were not met.
Many studies perform EFA’s and CFA’s only on a separate sample from that used in
EFA, however, van Prooijen and van der Kloot (2001) found that models generated through EFA
often were not confirmed in CFA on the same sample. If this were the case, then attempts to
cross-validate would likely be unsuccessful, not necessarily because the measure is not
generalizeable, but possibly because of methodological errors in the EFA. By examining
whether the model hypothesized by the EFA results is confirmed in a CFA on the same sample,
future cross validation studies are strengthened, and substantive differences can be sorted from
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methodological problems. At this step, no model respecification was performed, in order to
minimize capitalization on chance.
With this rationale, a CFA was first performed on the same sample (Sample 1) as the
EFAs described above. Running a CFA on only the same sample as the EFA, however, is not
advised in the literature (van Prooijen & van der Kloot ,2001). If a CFA is not run on a separate
sample there is an increased risk that positive findings may not be substantive, but may be due to
unique response patterns or characteristics of the sample used in both analyses (Cudeck &
Browne, 1983). With these considerations in mind, an additional CFA was performed on
Sample 2.
On both CFAs, if the model demonstrated adequate fit, then it would be possible to
interpret the parameters generated by the model. The convergent validity of the items on each
factor in the model was then tested by examining whether the Average Variance Extracted
(AVE) was above .5 (standardized factor loadings were examined to see whether the average
squared loading for each factor was above .5 (Hair, Babin, & Anderson, 2010). The AVE was
calculated by squaring the values for each of the factor loadings and computing an average for
the factor. This provides an estimate of the average amount of the variance of the indicators is
explained by the latent factor. The .5 cutoff was chosen because if the AVE value was not above
.5, this would indicate that less than 50% of the variance of the items was explained by the
factor, and conversely, that over 50% of the variance was attributed to error. Discriminant
validity was examined by comparing the AVE of the factors to the Maximum Shared Variance
(MSV) between factors (Fornell & Larcker, 1981). This was calculated by squaring the highest
correlation between the dimensions. If the AVE value for a factor was greater than its MSV, this
would indicate that the within factor variance was higher than the between-factor variance.
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Reliability. Internal consistency reliability was computed using two methods:
Cronbach’s alpha (Cronbach, 1951) and Raykov’s rho (Raykov, 1997a). Cronbach’s alpha was
computed due to its widespread usage, thus allowing for a point of comparison between the
CAMOS and existing measures. Alpha, however, has been criticized for its usage with survey
data due to its requirement that the survey items are tau equivalent measures of the construct
being assessed, an assumption which is not often met in social science research (Raykov, 1997b).
If this requirement is not met, then alpha may over or under-estimate the reliability of the scale,
with no way of knowing which was occurring. The author did not anticipate that the CAMOS
would meet the assumptions of tau-equivalence (few psychological measures do), thus, alpha
would be interpreted tentatively and supplemented with Raykov’s rho. A value of at least .8 was
determined to be an optimal minimum threshold for reliability (Streiner, 2003).
Raykov’s rho is a reliability coefficient that can be used with congeneric measures,
meaning that the items do not cross load, but are not required to have nearly equivalent factor
loadings (Raykov, 1997a). This appeared to be more congruent with of the type of model that
would be likely be generated in this study. Additionally, rho assumes unidimensionality of the
construct being assessed, thus it is required to perform a CFA on each individual dimensions for
both samples (Raykov, 1997a). Raykov’s rho uses the parameters of a CFA model in order to
generate the reliability index, thus a CFA was performed on each dimension for both samples.
Maximum-Likelihood (ML) estimation was used due to there being no way to compute rho
based on the parameters generated with Weighted Least Squares estimation. As with the
previous CFAs, it was important to establish that each dimension adequately fits the observed
covariance matrix, otherwise the parameters used to calculate the coefficient may not have been
accurate and could produce misleading findings (Raykov, Rodenberg, & Narayanan, 2015). Fit
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was evaluated for each dimension based on the same criteria used for the other CFA models in
the current study, except that with ML the Standardized Root Mean Square Residual (SRMR) is
also used. Based on Hu and Bentler’s (1999) cutoff criteria, an SRMR of < .08 would suggest a
good fitting model, although, as discussed above, this cutoff should not be held as absolute.
Raykov’s rho coefficients can be interpreted in the same way as alpha, thus the same cutoff
values were used.
Full form comparison. An essential component of determining whether a short form
adequately captures the construct of the full form is to examine whether the retained items
capture the breadth of the original construct (Smith, McCarthy, & Anderson, 2000). If such an
analysis is not undertaken, then relying exclusively only on empirical criteria may narrow the
construct to the point that it will not be measuring the same construct as the full form, and may
be reliable but not valid (Smith et al., 2000). Thus, the author examined each dimension to
determine whether the major aspects of the full form dimension were retained in the shortened
version. Following this, each short form dimension was correlated with its respective full form
counterpart. If the major facets of the construct of the full form were maintained, and the
correlations were sufficiently high this would provide evidence that the short form was assessing
the same construct as the full form.
Convergent validity. One essential test to determine if a measure is valid is to examine
whether it is correlated with scores on another measure that assesses a similar construct. In
developing a short form, this would involve examining whether it correlated with existing
measures at a similar level to the full form. Smith and colleagues (2000) have discussed the
importance of not assuming that the convergent validity of the full form of a measure is
applicable to short form, thus it is important to perform the analyses on both forms. If the
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correlations were found to be similar, this would provide evidence that the latent construct being
assessed in the short form was not substantially different from the full form. Pearson
correlations were performed between the CAMOS dimensions and the following measures.
The Outcome Questionnaire 45 (OQ-45). The OQ-45 is a 45-item instrument intended
to measure client progress in therapy along three dimensions: subjective distress, social roles,
and symptom distress (Lambert et al., 1996). Lambert et al. (1996) found the OQ-45 to have
excellent internal consistency reliability and strong concurrent validity with several measures of
distress including the Beck Depression inventory and Symptom Checklist-90. It is one of the
most commonly used ROM systems in the United States (Hatfield & Ogles, 2004)
The Minnesota Multiphasic Personality Inventory (MMPI-II). The MMPI-II is a 567item assessment of personality characteristics and pathology (Butcher & Pope, 1992). The
MMPI-II is composed of 10 primary clinical scales, as well as over 100 subscales to provide an
in-depth examination of a person’s patterns of pathology. Recently, the MMPI-II primary scales
were updated, with the resulting measure being called MMPI-2 RF (Ben-Porath & Tellegen,
2008). This update restructured the clinical scales of the MMPI-2 using a subset of the items in
the original version in order to improve its psychometric properties, and is intended to
supplement the original version. This study will use both the restructured and original clinical
scales, as well as selected subscales that are theoretically relevant to the dimensions of the
CAMOS.
Multidimensional Self-Esteem Inventory (MSEI). The MSEI (O’Brien & Epstein,
1988) is a 116-item scale designed to measure various aspects of a patients’ self-perceptions and
self-esteem. The MSEI provides 11 scores, including a global composite score, 8 self-esteem
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sub-scales, an identity integration scale and a validity scale. The MSEI has been found to have
acceptable internal consistency reliability as well as concurrent and discriminant validity.
Theistic Spiritual Outcome Scale (TSOS). The TSOS is a 17-item scale that assesses
theistic spirituality in 3 domains, and also provides a total score based on these domains (Love of
God, Love of Self, Love of Others). Richards et al. (2005) found the TSOS to have excellent
internal consistency reliability as well as convergent and discriminant validity. It was
hypothesized that the TSOS would correlate highly with the spirituality dimension of the
CAMOS. In concurrent validity analyses, only the TSOS scores for clients in sample one were
used. This was because respondents from sample two who were not religious or spiritual often
responded with the lowest possible answer for each item, thus providing a response set that
rendered interpretation of the correlations difficult.
Results
Removal of Rarely Endorsed Items
In order to identify the items that had 50% of respondents answer at “Never” or “Rarely”
(or “Always”/”Almost Always for positively worded items), descriptive frequency statistics were
calculated in SPSS on sample 1. In examining the frequencies, 18 items were found that 50% or
more of the respondents in sample 1 endorsed at “rarely” or “never.” These items were removed
from future analyses. With these items removed, the work concerns dimension from McBride’s
model was left with 3 items, which was less than the required minimum of 4 items for a
dimension. Additionally, in McBride’s model, this dimension showed relatively weak reliability
and concurrent validity. With these considerations, the remaining items in the work concerns
dimension were dropped.

22
EFA 1
Prior to beginning the EFA, items that were a part of McBride’s method bias factor (due
to positive wording) were excluded. This left some positively worded items, but only those that
loaded more highly on a substantive dimension that on the method factor. An additional item
presented a likely method bias, in that it was nearly identical to another item except for one
word. This was removed as it was part of a dimension which had many items, and was not
conceptually essential. These exclusions left 35 items to be analyzed in the EFA.
EFA was performed on sample 1 using Mplus 7.1 and the extraction and rotation
procedures described in the methods section. Parallel analysis of the first EFA on sample 1
suggested retaining 5 factors. In examining these factors, their groupings were both interpretable
and consistent with the factors identified in McBride’s analysis. The 5 factor model accounted
for 60% of the total variance of the data. Within the common variance, 60% was accounted for
by factor 1. This indicates that one factor was accounting for the majority of the variance of the
model. These estimates should be interpreted tentatively due to the fact that this EFA used an
oblique rotation which allows for correlations between the factors. Thus, the exact amount of
variance accounted for by a factor was difficult to ascertain due to the fact that some of the
variance was shared between multiple factors. The exclusion criteria described previously were
then employed. Three items were removed based on the cross loading criteria (difference of
highest loadings <.2) and one item was removed due to the loading criterion (loading <.4). The
factors all had significant correlations with each other, but none were above .5, indicating that
they were likely distinct, but related, factors.
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EFA 2
With the items removed that did not load well or that cross loaded to an unacceptable
degree, it would be possible to obtain a more precise model. This EFA used the same rotation,
extraction, and retention procedures as the previous analysis. Parallel Analysis suggested
retaining 5 factors. These factors accounted for 62% of the total variance. Within the common
variance, the percentage of variance explained by the 5 factors were: 57%, 14%, 11%, 9%, and
8%. Three items were removed due to not meeting the requirement of loading at .5 or above,
and no items were removed due to the cross-loading exclusion criteria. The removal of these
items left 3 dimensions with 4 items, while one factor had 10 items and another had 6. The
dimension with 10 items was deemed to be still too lengthy for the short form, but met all
empirical criteria for inclusion. Thus, a rational content analysis was performed in order to
remove items that appeared to carry the least amount of theoretical importance. Upon examining
the items in this dimension, all but three were symptoms of an anxiety or depressive disorder
according to the Diagnostic and Statistical Manual for Mental Disorders (5th ed.; DSM-5;
American Psychiaric Association, 2013). These three items were also redundant or excessively
broad to the point of not adding much clinically relevant information, and thus were removed
from the model. The model that emerged from this analysis had 25 items divided up into 5
dimensions: Therapy Expectations (4 items), Relationship Concerns (6 items), Psychological
distress (7 items), Spiritual concerns (4 items), and Physical Health concerns (4 items). The
content of the dimensions closely resembled that of McBride’s model and there did not appear to
be a substantial loss of content breadth in any factor. Additionally, all dimensions correlated at
>.90 with their full form counterpart, providing further evidence that the theoretical core of each
dimension was maintained. All items loaded on their respective dimension at .5 or higher and
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did not have any cross-loadings above .2, making this model an excellent candidate to be tested
in CFA.
CFA on Sample 1
As discussed in the methods section, an important step in determining the factor structure
of the CAMOS short form was to examine whether the model developed in the EFAs could be
confirmed through a CFA on the same sample before moving to cross-validation. Therefore, a
CFA was performed on sample 1 with Mplus 7.1 using Weighted Least Squares estimation due
to the categorical nature of the items. The model demonstrated good fit, with all indexes being at
or near the optimal values proposed by Hu and Bentler (1999). The fit statistics were as follows:
Chi-square= 616.7, df=265, p=0.00, RMSEA=.066 (.059-.073), CFI= .954, TLI=.948. These
values suggest a good fitting model, and that the parameters estimated in the CFA are
interpretable.
Convergent and discriminant validity of factors. Average Variance Extracted (AVE)
and Maximum Shared Variance (MSV) were calculated (See table 2) for each dimension. All
dimensions had an AVE of at least .5, providing evidence for the convergent validity of the
indicators on their respective factor. No dimension had a higher MSV than AVE, indicating that
more variance was explained within the factors than between them. The Relationship Concerns
dimension, did however, come very close to having an MSV that was higher than the AVE
(AVE=.54, MSV=.52) due to its high correlation with the Psychological Distress dimension.
This suggests that these dimensions may have substantial overlap. Overall, these findings
provide support for the convergent and discriminant validity of the 5 CAMOS factors for sample
1.
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Table 1
Sample 1 Confirmatory Factor Analysis
Item

PD

I felt worried, agitated, fearful, or tense

.81

I felt sad or depressed

.88

I thought about past personal failures/ mistakes

.79

I had thoughts or images that I couldn't get out of my head

.63

I felt powerless or stuck in my problems

.75

I had difficulty concentrating or remaining focused on a task

.61

I felt worthless or "not good enough"

.88

RC

I felt misunderstood by my loved ones and friends

.83

I felt hurt or disappointed by how others behaved

.85

I felt concerned about my relationships

.68

I felt accepted by my friends and loved ones

SC

TE

PC

-.67

I felt sad about how I acted towards others

.70

I felt irritated and angry towards others

.65

I felt a loss of inspiration or spiritual direction

.92

I felt distant in my relationship with God or my Higher Power

.89

I felt concerned about my religious or spiritual life

.64

I felt guilt over mistakes that were inconsistent with my religious beliefs

.74

I had concerns about beginning therapy

.84

I felt anxious about beginning therapy

.80

I felt uncertain about whether I can be fully open with my therapist

.69

I had doubts about whether my therapist will understand my concerns

.72

I felt physically well and healthy

.83

I experienced physical pain or discomfort

-.75

I felt light headed, weak, or fatigued

-.81

I had a stomach ache or other gastro-intestinal problems

-.62

Note. PD=Psychological Distress; RD=Relationship Concerns; SD=Spiritual Concerns; TE=Therapy Expectations; PC=Physical Concerns.
All loadings were significant.

Internal consistency reliability. Cronbach’s Alpha for each dimension was at or above
.8 for each dimension (see Table 2). This provides evidence that all of the short form scales
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demonstrated good internal consistency reliability. Raykov’s rho was also calculated due to the
considerations previously discussed. In order to calculate rho, CFAs were performed on each
dimension individually. These CFA models were evaluated for model fit in order to determine
whether the parameters generated by the model were interpretable, as these parameters would
provide the values for the calculation of rho. These estimates were obtained using a syntax
template from Raykov (2014) in Mplus 7.1, and used Maximum-Likelihood estimation due to
the lack of a procedure for calculating rho using Weighted Least Squares estimation. All
dimensions were found to have at least acceptable fit except for Therapy Expectations. With this
consideration, this dimension’s rho should be interpreted cautiously. Rho coefficients were all at
or above .85 (.85-.91), which indicates that most dimensions were underestimated in alpha.
These values provide compelling evidence for the internal consistency reliability of the data
obtained from this sample.
Table 2
CFA Reliability and Validity Statistics
Dimension

α

Sample 1
Rho AVE

Psychological Distress
Relationship Concerns
Spiritual Concerns

.89
.80
.84

.91
.85
.91

Therapy expectations
Physical Health
Concerns

.80
.80

.85*
.84

FF r

α

.59
.54
.65

MS
V
.52
.52
.39

.97
.96
.98

.90
.83
.81

.59
.57

.20
.38

.91
.92

.84
.82

Rh
o
.92
.86
.84
*
.87
.86

Sample 2
AVE
MSV

FF r

.63
.51**
.63

.54
.53**
.42

.975
.97
.99

.62
.60

.40
.54

.94
.90

Note. AVE=Average Variance Extracted, MSV=Maximum Shared Variance, FF r=Correlation with full form
*Model did not demonstrate adequate fit
**AVE less than MSV

CFA on Sample 2
Model fit. In order to minimize the probability of capitalization on chance, it was critical
that the factor structure identified in the previous analyses be replicated on a separate sample. A
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CFA was performed on sample 2 in order to provide this data. The procedures and decisionmaking criteria for this CFA were identical to the previous CFA. Model fit was found to be very
good (Chi-square 437.767, RMSEA= .056, CFI= .972, TLI=.969) indicating that the parameters
of the model were interpretable. Table 3 shows the factor loadings for each item on sample 2.
Convergent and discriminant validity. All dimensions had an AVE of at least .5,
providing evidence for the convergent validity of the factors. In four of the dimensions, the AVE
was substantially larger than the MSV. The only exception to this was the Relationship
Concerns dimension, in which the MSV of .53 with Psychological Distress was slightly higher
than the AVE of .51. These findings support the convergent validity of all five dimensions, but
suggest that the relationship concerns and psychological distress dimensions may have
substantial overlap.
Internal consistency reliability. Table 2 shows the values for both alpha and rho for
this sample. Cronbach’s alpha for each dimension was at or above .8 for each dimension. This
provided evidence that all of the short form scales demonstrated good internal consistency
reliability. Similar to sample 1, a CFA was performed on each dimension in order to generate
the parameters that would be used to calculate rho. All dimensions were found to have at least
acceptable fit except for Spiritual Distress. This may be due to the fact that many respondents
who did not identify as religious or spiritual often responded “never” to every item in the
dimension. With this consideration, this dimension’s rho should be interpreted cautiously or not
at all. All rho coefficients, except for Spiritual Distress (.84), were above .86 (.86-.92), which
suggests that most dimensions were underestimated in alpha. These values provide compelling
evidence for the internal consistency reliability of the data obtained from this sample.
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Correlation with full form.

All dimensions correlated with their full form equivalent

at >.9 (.90-.99). Similar cautions should be applied in interpreting these values as discussed with
the sample 1 data. Given that the majority of the items in each dimension were present in both
the full and short form, it is important that a conceptual analysis be performed, comparing the
construct coverage of the full and short forms (Smith et al., 2000).
The most obvious change from the intake form is the removal of the work distress
dimension. As was found in McBride’s analysis, this dimension demonstrated relatively low
reliability. Outside of this, the most changed dimension was physical health distress. Several
items from this dimension were removed due to a very low percentage of clients endorsing them
as concerns, with 75-85% of clients endorsing these items at “never” or “rarely.” Although this
limits the scope of the construct, these items did not seem to be relevant to most clients. The
Psychological Distress scale remained largely the same, except for the removal of items
assessing general concerns with thoughts, emotions, and behaviors. These items were viewed as
being redundant to the more specific items in the scale. Additionally, two items related to stress
were removed, as they were viewed as redundant to the item that assessed worry and fear. The
Relationship Distress dimension maintained all but two items from the intake form, with the
removed items being not often endorsed by most clients. This limited the construct in terms of
assessing angry or explosive interpersonal interactions, although this is likely covered by the
item assessing irritability and anger toward others. The Therapy Expectations and Spiritual
Distress dimensions remained identical to the intake form, except for the removal of 1 item from
each, thus the construct coverage is likely to be very similar to the full form.
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Table 3
Sample 2 Factor Loadings
Item

PD

I felt worried, agitated, fearful, or tense

.87

I felt worthless or "not good enough"

.87

I felt powerless or stuck in my problems

.84

I felt sad or depressed

.81

I thought about past personal failures/ mistakes

.77

I had difficulty concentrating or remaining focused on a task

.74

I had thoughts or images that I couldn't get out of my head

.59

I felt misunderstood by my loved ones and friends
I felt accepted by my friends and loved ones

RC

SC

TE

PC

.81
-.74

I felt irritated and angry towards others

.72

I felt concerned about my relationships

.71

I felt hurt or disappointed by how others behaved

.70

I felt sad about how I acted towards others

.55

I felt a loss of inspiration or spiritual direction

.88

I felt distant in my relationship with God or my Higher Power

.80

I felt concerned about my religious or spiritual life

.75

I felt guilt over mistakes that were inconsistent with my religious beliefs

.75

I felt anxious about beginning therapy

.90

I had concerns about beginning therapy

.87

I felt uncertain about whether I can be fully open with my therapist

.70

I had doubts about whether my therapist will understand my concerns

.67

I felt physically well and healthy

-.85

I felt light headed, weak, or fatigued

.82

I had a stomach ache or other gastro-intestinal problems

.74

I experienced physical pain or discomfort

.68

Note. PD=Psychological Distress; RD=Relationship Concerns; SD=Spiritual Concerns; TE=Therapy Expectations; PC=Physical Concerns.
All loadings were significant.

Convergent validity. The 5 dimensions of the CAMOS short form were compared to
several existing measures in sample 2 in order to understand in greater depth what each
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dimension was assessing. Table 4 shows the correlations of the CAMOS short form dimensions
with measures that were hypothesized to assess similar constructs as well as some that were
theorized to be different than the dimension. The following section also provides a conceptual
analysis of the constructs assessed in the context of
Psychological Distress. The Psychological Distress (PsD) dimension demonstrated
strong correlations with the OQ-45 Total (.812) score. This indicates that PsD accounts for
approximately 66% of the variance of the OQ-45 and provides strong evidence for its utility as a
valid measure for monitoring outcome in everyday practice. The strong correlations with the
MMPI-II RF demoralization scale (.661) indicate that this dimension may be assessing a client’s
degree of general distress and feelings of inability to cope with stress. PsD also demonstrated
moderately high correlations with the low positive emotions scale (.538) which suggests that it
may pick up on anhedonic or depressive symptoms in addition to demoralization. The
moderately high correlation with the dysfunctional negative emotions scale (.585) also provides
evidence that PsD is likely assessing anxiety, anger, or general emotional reactivity.

31
Table 4
CAMOS factor correlations
Sample 1

PD

TE

PHD

SD

Psychological Distress (PD)

-

Therapy Expectations (TE)

.44

--

Physical Health Distress (PH)

.62

.32

--

Spiritual Distress (SD)

.63

.17

.37

--

Relationship Distress (RD)

.72

.38

.50

.46

RD

--

Sample 2
Psychological Distress (PD)

-

Therapy Expectations (TE)

.64

--

Physical Health Distress (PH)

.73

.55

--

Spiritual Distress (SD)

.65

.44

.56

--

Relationship Distress (RD)

.73

.57

.54

.54

--

Additionally, this dimension demonstrated high correlations with the MMPI-II’s Anxiety
(.670) and Depression (.665) subscales. Overall, these results suggest that PsD is assessing
demoralization as well as symptoms of anxiety and depression. This dimension had low
correlations with the MMPI-2 RF Antisocial Behavior (.143) and Ideas of Persecution (.202)
scales, suggesting that it does not assess paranoid or antisocial symptoms.
Relationship Distress. The Relationship Distress (RD) dimension demonstrated
moderate correlations with several measures. Its moderately high correlation with the OQ-45
Interpersonal Relations score (.572) provides evidence that it is assessing general relationship
concerns. Additionally, its moderate correlation with the MMPI-2 Social Alienation scale (.498)
indicates that RD is tapping into a person’s feelings of loneliness and of potentially feeling
unloved or misunderstood. This is further corroborated by a large correlation with the MSEI
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Lovability (-.600) scale. The moderate correlation with the MMPI-II Family Concerns subscale
(.447) provides some evidence that RD may be assessing the degree of perceived social support
the client experiences. Given that there was only one large correlation, it may be necessary to
examine this further, however, there is evidence that this dimension is in fact assessing
relationship distress. Many ROM systems, however, have had difficulty obtaining large
correlations of relationship concern dimensions with existing measures of interpersonal problems
(Lambert et al., 1996; Kraus et al. 2005; Evans, 2012). Its low correlations with the MMPI-II RF
Low Positive Emotions scale (.222) indicate that the dimension is not assessing depressive or
anhedonic symptoms.
Physical Health Concerns (PHC). The PHC dimension had a large correlation with the
MMPI-2 RF Somatic Complaints (.619) as well as the MMPI-II Health Concerns scale (.616)
scales. This suggests that PHC is assessing physical discomfort or illness, but also possibly
assessing somatic or conversion symptoms. Additionally, PHC demonstrated a moderate
correlation with the MMPI-2 Physical Malfunctioning subscale (.433), which suggests that it
may be assessing some of the physical symptoms associated with depression. As expected, this
dimension does not assess psychotic or antisocial tendencies, as evidenced by low correlations
with the MMPI-II Bizarre Mentation subscale (.118) and MMPI-II RF Antisocial Behavior scale
(.101). These results suggest that PHC appears to be assessing distress due to physical heath or
psychosomatic concerns.
Spiritual Concerns (SC). The SC correlations were performed on sample 1 given that
this dimension on sample 2 had a problematic response set for those who reported not being
spiritual. The SC dimension had a moderately large correlation with the TSOS Love of God
scale (-.56) indicating that it is assessing a client’s perceived relationship with God as well as
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spiritual purpose in life. The highest correlation was with the TSOS Love of Self scale (-.668),
which provides evidence that the SC dimension is also assessing the client’s feelings of spiritual
worth and congruence with moral values. This dimension had very low correlations with the
MMPI-II RF Abberant Experiences (.074) and Antisocial Behavior (.115) scales. Overall, these
findings suggest that SC is assessing client’s spiritual concerns.
Therapy Expectations (TE). TE had a moderate correlation (.445) with the Negative
Treatment Indicators (TRT) subscale of the MMPI-II. The lack of a large correlation is not
entirely unexpected, as the TRT subscale has broader aims than was desired for the TE
dimension. Thus, aspects such as pessimism about therapist understanding and fear of selfdisclosure may not correlate very well with the TE dimension, but aspects such as fatalism and
avoidance of responsibility may not be as relevant for the TE dimension. This dimension did not
correlate highly with the OQ social roles scale (.238) or MMPI-II RF low positive emotions scale
(.288).
Table 5
Convergent Validity Correlations
PsD

RD

SD

PhD

TE

OQ-45 Total

.812

.543

.487

.662

.476

MMPI-II RF Low Positive Emotions

.538

.412

.362

.466

.288

MMPI II RF Dysfunctional Negative
Emotions

.585

.480

.347

.394

.341

MMPI II RF Demoralization

.661

.412

.457

.488

.375

MMPI II Obsessiveness

.543

.413

.377

.404

.335

OQ-45 Interpersonal relations

.621

.572

.449

.482

.341

MMPI-II Social Alienation

.397

.498

.259

.248

.311

MMPI-II Family Discord

.239

.449

.172

.131

.131

34
.447

MMPI II Family Problems

.298

MSEI Lovability

-.647 -.608 -.397 -.495

MMPI-II RF Somatic Complaints

.443

.404

.337

.619

.288

MMPI-II Health Concerns

.456

.465

.355

.616

.309

MMPI-II Physical Malfunctioning

.398

.335

.308

.539

.209

TSOS Love of God

-.427 -.344 -.560 -.151

-.350

TSOS Love of Self

-.561 -.391 -.668 -.229

-.295

MMPI-II Negative Treatment
Indicators

.520

.445

.375

.160

.329

.238

.392

.213
-.496

Note. Expected theoretical correlation bolded. MMPI-II= Minnesota Multiphasic Personality Inventory 2, MMPI-II
RF = Minnesota Multiphasic Personality Inventory 2 Restructured Form, OQ-45= Outcome Questionnaire 45.

Discussion
The present study found strong evidence to support the reliability and validity of the five
factor 25-item short form of the CAMOS. The short form demonstrated excellent model fit in
samples from a college counseling center and inpatient eating disorder clinic. The factor
loadings were sufficiently large to suggest strong convergent validity, and the ratio of average
squared factor loadings to maximum squared correlations between dimensions suggested that all
but one dimension (Relationship Concerns) in one sample did not demonstrate a problematic
overlap with another dimension. All but one dimension demonstrated strong correlations (>.60)
with a theoretically related measure, with the only scale that did not (Therapy Expectations),
demonstrating a moderate correlation with a criterion measure. Every short form dimension
demonstrated strong internal consistency reliability with both samples, with all being above .8 on
two separate indexes. All short form dimensions correlated with their full form counterpart at
greater than .9, suggesting that the CAMOS short form is a suitable alternative to the full form.
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With the removal of items that were highly positively skewed, only items that allowed for
improvement for most clients were maintained.
With this short form in place, the CAMOS now has a brief standardized core that has
strong evidence of reliability and validity. This short form model can serve as required items
that are administered to clients on a session by session basis, thus providing a standardized
routine outcome monitoring system. The items that were not used in the short form can serve the
purpose of optional items that can be added to the CAMOS if the clinician feels that they are
important to assess. This potentially resolves the problem of how to include items that are of
obvious clinicial utility (i.e., items about suicidal or homicidal ideation), but do not fit well into
specific factors (Kraus et al., 2005). This approach is similar to hybrid measurement systems
such as the Psychological Outcome Profiles (Ashworth et al., 2007), and the Individualized
Patient Progress System (IPPS; Sales & Alves, 2012), in that it combines global and
individualized assessment approaches, but with the short form model, the CAMOS offers several
advantages relative to these systems. One advantage is that the CAMOS allows for a therapist to
create a tailored measure for all of their clients with just a one-time five minute investment of
their time. Once the items for the template have been selected and authored, the therapist or
treatment site could opt not invest any more time, and the measure will be adapted to their needs.
An additional benefit is that if client-level tailoring is desired, the therapist can select from the
existing item pool, and add items with a clicking of a check box. These features allow the
CAMOS to adapt to the needs of individual therapists and clients, while substantially decreasing
the time burden to both client and therapist relative to hybrid measures. The development of the
short form of the CAMOS is what allows for this tailoring system while still being feasible for
session-by-session administration. Thus, the CAMOS’s tailoring system offers a promising
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alternative to hybrid systems in that it provides a more structured and efficient way of tailoring,
while still giving clinicians the ability to author items if they so desire.
The tailoring feature could be a step toward resolving the issue of having an adequate
balance of providing a clinically meaningful and psychometrically sound assessment while still
keeping the measure brief. In the ROM literature, the emphasis appears to be on treatment sites
finding an outcome measure that balances relevance and practicality in the context of their site
(Boswell et al., 2015; Tarescavage & Ben Porath, 2014). These approaches, however, do not
account for the possibility that individual therapists may have different preferences for the type
and amount of information desired, and that these preferences could change relative to the needs
of specific clients. Thus, even if a site is able to reach a consensus of which measure most
therapists at their site found appropriate, which some, such as Meehan and colleagues (2006),
have found to be a difficult task, it would still ignore individual needs. The clinically adaptive
features of the CAMOS address this issue by allowing the measure to adapt to specific sites,
therapists, and clients.
With this blend of gathering standardized data and easy tailoring options, new ways of
implementing ROM systems become available that could help resolve the impasse between
ROM developers and clinicians. With this system, clinician concerns about relevance no longer
need to be seen as “obstacles” to be overcome, but as valuable information that can be
incorporated into the measurement system (Boswell et al., 2015). Additionally, the results of the
present study suggest that this accommodation would not come at the expense of comparability.
Instead of researchers needing to convince clinicians that their measures are relevant, and
minimizing aspects that are not included in the system, they can encourage clinicians to adapt
assesment and make it relevant to the populations and individual clients that they serve . This
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would be more in line with the recent push in the ROM literature to establish more bottom-up
implementation procedures (Mellor-Clark et al., 2014), as well as developments in the
organizational behavior literature about the determintal effects of demonizing “resistance” (Ford
et al., 2008; Thomas & Hardy, 2011).
This could change the narrative of ROM implementation efforts from one of heroic
researchers attempting to overcome the irrational objections of clinicians in order to bring about
scientifically informed practice, to one of collaboration. With existing ROM systems, the
possibilities for adaptation are limited to primarily logistical concerns (Boswell et al., 2015).
The individual therapist has no say in defining the items and constructs used to define their
treatment outcomes, nor in determining the length of the survey. In contrast, the philosophy and
features of the CAMOS can encourage and even seek after individual input from sites and
clinicians, without threatening the legitimacy of the assessment system. As this information is
added by clinicians, it could potentially help to expand the researcher’s views of what kinds of
outcomes are valued by clients and therapists, leading to further refinements of the standardized
items. In this approach, the researcher is no longer imposing a definition of outcome, but
providing a platform that allows for researchers and clinicians and clients to co-create the
definition of outcome.
The creation of the CAMOS short form allows for these changes, while still offering the
major features that make ROM systems so desirable. The results of the present study provide
evidence that the CAMOS can be used to evaluate outcomes in routine practice, and to provide
aggregate data that can be used to evaluate the efficacy of treatment for large groups of clients
and therapists. The evidence gathered in this study for the reliability and validity of the short
form is a first step toward generating expected treatment response curves once more data is
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obtained (Lueger et al., 2001). It is hoped that, similar to the studies performed by Lambert and
colleagues, the CAMOS can help to decrease the incidence of client deterioration throughout the
course of treatment (Shimokawa et al., 2010). In addition to providing the benefits associated
with traditional ROM systems, it is hoped that the clinically adaptive features of the CAMOS
will allow it to provide additional benefits.
In terms of evaluating the efficacy of treatment for specific sites, the CAMOS could
allow for a more nuanced picture of the benefits of treatment. In addition to evaluating the
standardized portion of the measure, administrators could qualitatively examine the results of the
therapist’s unique items, to see if there are benefits to the clients that were not captured within
the relatively narrow scope of the global items. This could allow clinicians to have a voice in
defining the types of outcomes by which they will be evaluated and facilitate productive dialogue
about the clinician’s performance. At an individual client level, the CAMOS tailoring features
could allow for enhanced responsiveness in treatment (Stiles, 2013). As the measure adapts to
the needs of the client, it is possible that the client could perceive the therapist as having a
greater understanding of their concerns, due to the measure adapting to their needs. It could also
help therapists to see if the types of outcomes and processes that they are viewing as important to
treatment, are in fact valued by the client.
Finally, if clinicians have access to data that is directly relevant to their therapeutic
approach, and to the specific context of the client, it could allow for assessment that more
directly informs treatment. Several studies have documented how few clincians use the reports
associated with ROM systems (Garland et al., 2003; Trauer, 2010b). This may be due to the
atheoretical nature of the measures, which provides primarily descriptive information about the
client (Persons, 1991). With the CAMOS’s approach, the therapist could assess areas directly
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relevant to the specific co-created outcomes with individual clients, as well as more theoryspecific outcomes and processes. This relevant and easy to tailor information could help to
increase the usage of ROM reports by clinicians, and thus increase existing benefits of ROMs as
well as potentially offer new advantages.
If the usage rates of ROMs can be increased, as well as the quality of the data received
from ROMs improved, this could lead to a more full realization of the goals of Evidence Based
Practice in Psychology (EBPP). ROM is viewed as a crucial aspect of the EBPP vision (APA
Presidential Task Force on Evidence-Based Practice, 2006). If the CAMOS is successful in
increasing clinician ROM usage, and broadening the scope of the outcomes measured, then it
could be a vital contributor to EBPP. Current ROM models rely solely on research (with input
from a few clinicians) to define the outcome criteria by which therapeutic encounters are
evaluated, with the integration of clinical expertise and client culture and values occurring after
the measurement process is complete (Boswell et al., 2015). The tailoring features made
possible by the development of the short form of the CAMOS allow clinical judgments and
client culture to be more than post-hoc factors that are used to contextualize the results of ROM,
but integral aspects of the definition of outcome. In our view, this approach is more consistent
with the spirit of EBPP, as well as with the growing emphasis on multiculturalism in the field of
psychotherapy research (Lee, 2014). Thus, the CAMOS’s tailoring features are more than just a
gimmick to attempt to get clinicians to start using ROM, but a way to facilitate the integration of
the principles of EBPP into assessment as well as treatment.
Limitations
One limitation of this study was that it used the same samples as McBride’s analysis. In
order to minimize capitalization on chance, the samples were divided up differently for the
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present study. In McBride’s analysis, the samples were stratified by gender, then combined and
split. In the current study, the samples were left separate, with more exploratory analyses
performed on the college counseling center sample, and the final CFA being performed on the
inpatient eating disorder sample. Although this distinction did provide some differentiation, the
fact remains that the same participants were used in both studies. Also, one of the treatment sites
was a female-only inpatient eating disorder facility, thus, the overall sample was likely underrepresentative of males. This limitation is somewhat offset by the finding that the factor
structure also held up with the university counseling center sample, which had a substantial
number of male participants, but additional replication with more clinical samples may be
necessary. Finally, the samples were relatively homogenous in terms of their racial
identification, thus additional cross validation with more diverse populations is necessary.
Despite these concerns about the sample, the tailoring features of the CAMOS allow for items
that were not included in the short form, but may be relevant for specific groups, to be added
back into the measure easily. Thus, the items removed from both forms of the CAMOS can still
be accessed and used in clinical settings.
Another limitation is the cross-sectional nature of the data. One of the primary purposes
of the CAMOS is to be a measure of therapeutic change. This study addressed sensitivity to
change in the sense of removing items with little room for improvement, however, additional
longitudinal studies will need to examine whether the items on the short form demonstrate
change in response to relevant intervention. Such longitudinal analyses, however, were beyond
the scope of the present study.
The removal of the Work Distress dimension from the final short form model is a
limitation in the theoretical and clinical utility of the short form. There are several possible

41
reasons for the inability of the Work Distress dimension to hold up well in the current study.
The first is that occupational and academic functioning may in fact be two separate constructs.
Thus, it may be necessary to develop separate academic and employment concerns dimensions in
order to account for this possibility. It is also possible that occupational functioning was not a
highly relevant variable for the populations that were selected for this study. Many college
students are not employed due to their academic demands, and patients at an inpatient treatment
center are often not working. Thus, it could also be the case that attempting to validate this
dimension on a demographic that is more likely to be employed could yield more positive
findings. The difficulty in validating an occupational functioning dimension, however, is not
unique to the CAMOS, as other ROM systems have struggled to create a stable measure of social
role functioning (Kraus et al. 2005; Lambert et al., 1996; Tarescavage & Ben-Porath, 2014).
Future Directions
Studies are currently underway to cross validate the factor structure of both forms of the
CAMOS in more culturally diverse populations and in different types of treatment settings. Data
has already been gathered in order to replicate the factor structure on a non-clinical sample, and
to create indexes of clinically significant change (Jacobson & Truax, 1993). Initial results are
promising that the factor structure fits with a non-clinical sample, and that the CAMOS
dimensions can differentiate between clinical and non-clinical populations. These studies should
also test the invariance of the parameters of the CFA model in different samples and with
different groups. Additional studies are also underway to examine the stability of the factor
structure across repeated administrations, as well as to evaluate the CAMOS’s sensitivity to
change. These will be essential to the validity of the CAMOS, in that it was designed to be a
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measure of change as a result of therapy. These studies will also need to provide support for the
Therapy Progress dimension that begins after the first session.
A revision of the Work Distress dimension will be necessary in order to make it both
clinically relevant and psychometrically sound. An updated Work Distress and a new School
Distress scale are currently in development. Initial findings look promising for improved
psychometric performance by separating occupational and academic functioning into two
separate scales. Additionally, a new scale of cultural distress, related to perceived
microagressions, is currently in development and being tested in various treatment sites
throughout the country. This could be a step forward in helping the CAMOS to potentially
become a tool for enhancing multicultural awareness and competence in clinicians.
Finally, the most important consideration of the value of the CAMOS will be evaluating
whether it can be both feasible and relevant in clinical practice. Additional research should
examine ways to optimize reporting systems so that they provide the most useful information to
clinicians in as concise a manner as possible. Also, examining clinician usage rates of various
CAMOS features will be highly important to determining whether the philosophy and features of
the CAMOS do in fact lead to greater clinician acceptance of a ROM system in clinical practice.
Additional studies will also need to examine whether the use of CAMOS reports improves
outcomes, and how these results compare to previous findings about the benefits of using ROMs
in clinical practice.
Conclusion
This study found support for the reliability and validity of a short form of the CAMOS.
This short form provides the psychometric foundation needed to allow for accurate aggregate
data analysis on a session-by-session basis, while leaving room for additional clinician tailoring.
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Future psychometric studies will need to address the issues of clinical significance and
sensitivity to change, but this study provides a strong base from which to proceed with these
types of analyses. Overall, these results show that the CAMOS short form is a promising
measure that can hopefully be facilitative of more widespread implementation of ROM systems
while still empowering the voice of the clinician and client.
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APPENDIX A: Literature Review
Evidence-Based Practice
In the late 1980’s and early 1990’s a movement called Evidence-Based Practice (EBP)
began to gain considerable influence in the health care professions (Walker & London, 2007).
Initially beginning in the field of medicine under the title “Evidence Based Medicine”, this
movement called for health care practitioners to provide evidence that the treatments they were
providing had scientific evidence to back their usage (Sackett, Rosenberg, Gray, Haynes, &
Richardson, 1996). Some of the major motivating factors behind this movement were: the idea
that healthcare interventions should be applications of scientific knowledge, a desire to control
costs and have evidence that the procedure being paid for (by the patient or insurance company)
was necessary, and an ethical imperative to provide the best possible treatment to patients
(Bower & Gilbody 2010).
Soon these ideas began to permeate psychotherapy, and questions began to be asked
about which types of psychotherapy were most effective for which disorders and whether
clinicians were using these (Task Force on Promotion and Dissemination of Psychological
Procedures, 1995). Although psychotherapy had research to support its general efficacy as an
intervention (Smith & Glass, 1977), there was some concern that the therapies that were used in
the research were not being used in clinical practice (Wampold, 2001). Therefore, it was
possible that clinicians were doing therapy that did not have scientific support. This was
especially problematic because insurance companies would likely not be willing to pay for
interventions that had no evidence of their effectiveness. Even if the intervention did work, if
there was another that was shown to be superior, then that should be the one used.
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Empirically-Supported Treatments. In 1995, with the legitimacy and funding of
psychotherapy hanging in the balance, the Division of Clinical Psychology of the American
Psychological Association (APA) began an initiative called Empirically-Supported Treatments
(EST; Task Force on Promotion and Dissemination of Psychological Procedures, 1995). The
goal of this initiative was to meet the demands of EBP by identifying the treatments that had
empirical evidence to support their usage with specific diagnoses and to ensure that these
treatments were used by clinicians. Therefore, a list of treatments that had empirical support for
specific disorders was assembled, and clinicians were urged to use these in order to receive
insurance funding and to practice ethically. This list would be updated frequently as new
innovations and findings emerged (Chambless et al., 1998). The criteria for a treatment to be
seen as empirically supported were:
1. At least two Randomized Controlled Trials (RCT) demonstrating that the treatment is
(a) superior to placebo or another treatment, (b) equivalent to an existing EST. Or at
least nine Single-N experimental studies showing efficacy of the approach.
2. Studies must use treatment manuals
3. Characteristics of the client samples must be clearly specified
4. Experiments must have been done by at least two different investigators or teams.
With the establishment of the EST paradigm, it appeared that some of the major pressures
of EBP had been addressed: Practitioners would primarily use treatments that had firm evidence
to back their usage for specific problems, funders and consumers could know that their money
was being spent on something that was proven to be effective. Additionally, it would provide
clear guidelines for ethical practice, and would bring a rigor used in pharmaceutical trials to
psychotherapy research and practice
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The EST paradigm was met with substantial backlash from the field. The primary
objection centered around the validity of the criteria for inclusion in the Empirically Supported
Treatment list (Elliot, 1998). Some of these concerns included the following: No empirical
proof existed that RCTs had external validity in treating the specified disorders (Westen,
Novotny, & Thompson-Brenner, 2004), the criteria were biased against certain kinds of
therapeutic approaches such as humanistic and psychodynamic therapies (Bohart, O’Hara, &
Leitner, 1998), methodological criticisms of RCT as a means of establishing the efficacy of
treatments (Wampold, 2001), arguments that the criteria were too lenient, and claims that the
selection of the criteria represented a political process of creating ideological and methodological
monopolies (Smith, 2009).
Evidence-Based Practice in Psychology. This debate continued for nearly a decade
before the APA took an official stance on a new policy. The new policy, called Evidence Based
Practice in Psychology (EBPP), defined EBP as “the integration of the best available research
with clinical expertise in the context of patient characteristics, culture, and preferences.”
(American Psychological Association Presidential Task Force on Evidence-Based Practice,
2005, p.1). This approach represented a substantial departure from the EST approach and
addressed many of the concerns with the EST paradigm. In the EBPP stance, research still held
significant sway in terms of its importance in clinical decision making; however, it was no longer
the sole determinant in deciding which treatments should be used. The definition of EBPP added
“clinical expertise” and “patient characteristics, culture, and preferences” as essential elements to
clinical decision making. The report defined clinical expertise as the ability to use research,
training, and previous experience to tailor treatment to the individual. Some of the components
of clinical expertise identified in the report are: treatment planning, implementing interventions,

56
monitoring client progress, adapting to client’s culture and preferences, and continually
acquiring new skills. Although research is not separate from these tasks, there is considerable
clinical skill involved for the therapist to synthesize and apply research and clinical observations
to a specific client’s situation.
In addition, EBPP incorporated a broader definition of what qualifies as evidence (Wendt
& Slife, 2007). In fact, the task force report purposely did not include specific guidelines for
what qualifies as evidence for efficacy (Wampold, Goodheart, & Levant, 2007). In the report,
the task force listed various types of research that would be considered evidence to support the
use of an intervention such as: effectiveness and efficacy research, cost effectiveness, treatment
utilization, and more. In addition several research methodologies were outlined, although they
were not meant to be an exhaustive list: clinical observation, qualitative research, RCTs, singlen, meta-analysis and more. It is clear to see that EBPP took some of the criticisms of the EST
paradigm about the narrowness of the inclusion criteria very seriously and used these to expand
the definition of what qualified as evidence.
Although many lauded this new paradigm for its increased flexibility and responsiveness
to the criticisms of the EST paradigm, there was still considerable debate about this report
(Wampold et al., 2007). One of the major critiques of this report was that it did not provide a
concrete definition of what constitutes sufficient evidence to justify the use of a practice (Stuart
& Lilienfield, 2007). The EST model had a very clear and concrete definition of what
constituted sufficient evidence for the use of a treatment: if the treatment demonstrated in two
RCTs that it was superior to placebo, it was a good treatment. In EBPP, were no specific
criteria, but general principles of how the clinician should make decisions. However, with
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principles instead of guidelines, it becomes more difficult to keep clinicians accountable, and to
provide firm rules about what kinds of interventions should be funded by insurance companies.
In responding to this issue, Wampold and colleagues (2007) pointed out that they
intentionally did not give criteria for what evidence and how much of it is needed for a specific
treatment to be justified in use. EBPP was not designed to be provide prescriptive guidelines for
clinicians. They discuss how, instead of only identifying treatments that work in laboratory
setting, that clinicians should engage in routine outcome measurement and monitor treatment
progress. Whereas EST’s solution to the issue of accountability was to identify research
supported treatments, and have clinicians use those exclusively, EBPP emphasizes the
importance of looking at what is already being done in practice in addition to using research
support treatments. If clinicians could provide evidence that their interventions were providing
measurable benefit to clients, then they have evidence to support their use of that intervention.
Additionally, clinicians would be able to examine in real-time if their interventions were not
working, and potentially change them.
Routine Outcome Monitoring
As of the time of the EBPP report, several measures existed that were designed to
accomplish the goals outlined in the report (Stuart & Lilienfield, 2007). This paradigm of
measures has been called by many names (Routine Outcome Measures, Routine Outcome
Monitoring Systems, Progress Monitoring), but for the sake of this paper they will be called
Routine Outcome Monitoring (ROM) systems. The literature has focused primarily on two ways
that the ROMs could ensure and possibly improve the quality of treatment: (a) Identifying
individual clients at risk for treatment failure and (b) examining the efficacy of therapists and
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treatment sites in the treatment of large groups of clients (Shimokawa, Lambert, & Smart, 2010;
Kraus, Castonguay, Boswell, Nordberg, & Hayes, 2011).
Improving individual treatment. In 1996, Howard and colleagues published an article
in American Psychologist that laid both the conceptual and practical framework on which most
ROM systems are based. They discussed how efficacy research has shown evidence of
interventions that are generally effective, but that this does not help clinicians with decision
making about the treatment of individual clients. With these considerations in mind, they
outlined a system that could potentially use the results of research and make them applicable at
the level of the individual client. Their solution rested on their previous work about the doseresponse relationship in psychotherapy (Howard, Kopta, Krause, & Orlinsky, 1986). This model
essentially posits that there exists a log linear relationship between the number of sessions and
outcome, and that treatment involves three phases: remoralization, remediation (symptom
reduction), and rehabilitation (improved functioning). These phases are sequential and if the
outcomes for each phase are not met by certain sessions, then the likelihood of treatment failure
increases (Howard et al., 1993). In sum, the course of a client’s treatment response could be
predicted.
Expected Treatment Response & Clinically Significant Change. If outcomes could be
predicted, then it could be possible to provide what Howard and colleagues called Expected
Treatment Response (ETR) curves that would allow clinicians to compare how an individual
client is progressing in treatment relative to other clients similar to them. This concept was
incorporated into a measure developed by Howard and colleagues called the COMPASS
(Howard, Lueger, Maling, & Martinovich, 1993) that assessed areas relating to the dose-response
model, and used these and 18 additional case mix variables, later reduced to 7 by Lutz,

59
Martinovich & Howard (1999), to form individualized ETRs for clients using Hierarchical
Linear Modeling procedures. A study by Leon, Kopta, Howard and Lutz (1999) examined the
question of whether the predicted ETR values matched observed data. They found that for 75%
of the ETRs, the predicted score was similar (the difference was less than measurement error) to
the observed scores, and found correlations of .57 between ETR slopes and observed slopes.
They also identified several moderating and mediating variables that had differential predictive
power in terms of predicting treatment failure. Lueger and colleagues (2001) provide a more
comprehensive review of the work of Howard’s team in developing the ETR technology, and is
recommended for interested readers.
In addition to the ETR system the COMPASS incorporated another concept that is
foundational to most ROMs, clinical significance. The concept of clinical significance
originated in the work of Jacobson and Truax (1991), which challenged the notion that statistical
significance was equivalent to clinically meaningful change. In contrast to depending on
statistical significance or effect sizes, the authors propose two alternative methods: Clinical
Cutoffs and Reliable Change Indexes. Clinical cutoffs were defined as the score on the outcome
measure at which the client’s score is more probable in the distribution of a non-clinical sample
than that of a clinical sample. This provides stronger evidence of improvement than relying only
on statistical significance because it is tied to the ‘real world’ distinction between those who are
in treatment and those who are not. One situation where this procedure could be inadequate is if
a client’s initial score is in the clinical range by a very narrow margin, and they drop to be
narrowly in the normative range by the end of treatment. Using the clinical cutoff criteria, the
client would be deemed to have improved despite showing very little change in their symptoms.
In order to account for this, Jacobson and Truax developed the Reliable Change Index (RCI),
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which provides a minimum value that a person must change in order to ensure that it is not
merely the result of measurement error. This value is a function of the reliability of the measure,
and suggests change that is above and beyond measurement error. With these two statistics,
Jacobson and Truax provided a means for measures to be more relevant to the reality of
clinicians.
The COMPASS incorporated both ETR and the concept of clinical significance into the
measure, thus providing multiple ways to evaluate the effectiveness of treatment at the level of
the individual client (Lueger et al., 2001). Due to the COMPASS being developed specifically
for a managed care company (Integra), it has not been as widely disseminated as many of the
other measures discussed in this review. Despite this, the ETR system developed by Howard and
his team, and the use of clinically significant change in an outcome measure are at the heart of
nearly every ROM system (Lambert, 2013).
The Outcome Questionnaire. Soon after the COMPASS, Lambert and colleagues
developed a measure called the Outcome Questionnaire 45 that built on Howard’s work (OQ-45;
Lambert et al., 1996). The OQ-45 bases its definition of outcome on a theory elaborated by
Lambert (1983) which posits three primary domains that must be included in an outcome
measure: symptom distress (intrapersonal distress), interpersonal functioning, and social role
performance (Lambert et al., 1996). The OQ-45 was developed for reasons similar to those used
in Howard’s work, as a means to provide evidence that a therapist’s interventions are effective
(Lambert et al., 1996), as well as to aid in predicting and preventing treatment failures (Lambert
et al., 2003). Like the COMPASS, the OQ-45 incorporates the concepts of clinical significance
as well as ETR (Lambert et al., 1996). The OQ-45’s ETR only uses two variables to predict
expected treatment response (compared to the 7 used in the COMPASS), initial OQ-45 score and
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early treatment response. These criteria were selected based on previous analyses which
revealed these to be the only variables out of many that accounted for a significant amount of
variance in predicting the outcome of treatment (Lambert, Hansen, & Finch, 2001).
Additionally, they created a signal alarm system that provided clinicians with color-coded
notices of whether the client was deviating from the ETR, making the results easily interpretable
for clinicians (Lambert et al., 2001).
What sets the OQ-45 apart from all other ROMs is the degree to which it has been
studied to determine whether it actually improves clinical outcomes (Goodman, McKay, &
DePhilippis, 2013). In 2001, Lambert and colleagues conducted a study to determine whether
the signal alarm system helped prevent treatment deterioration. Their study was a randomized
controlled trial in which clinicians were divided into two groups, with clients assigned to one of
two groups: an experimental group that received feedback based on the signal alarm system, and
a control group that did not receive any feedback. They found that the feedback group had 10%
more cases of reliable change than the control group, and 17% fewer clients who deteriorated by
the end of treatment. These encouraging findings led to two replications with similar results ,
and these three studies were then meta-analyzed (Lambert et al., 2002; Lambert et al., 2003
Whipple et al., 2003) In the meta-analysis, Lambert and colleagues (2003) compared the
experimental and control groups from the previous studies in order to determine whether the
feedback improved outcomes across studies. The overall sample size was approximately 2500
clients from a college counseling center. The effect size of the comparison between groups was
a modest .09. When comparing the rates of improvement of those who were on track to
deteriorate, however, a medium effect size of 0.39 was found (21% improved in control, 35% in
feedback group). Based on these results, Lambert and colleagues concluded that the feedback
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was helpful for those on track to deteriorate, but not necessarily for those who did not deviate
from the trajectory of the ETR. They also found that clients whose therapist received feedback
stayed in treatment longer if they were on track to deteriorate, and remained in treatment for less
time if they were on track to improve, providing evidence of cost-effectiveness of the OQ-45’s
feedback.
Following this meta-analysis, Lambert’s team performed several more replications, but
added another experimental group that incorporated their newly developed Clinical Support
Tools (CST); additionally, two studies added minor variations such as feedback to patients and
delays in reporting (Hawkins et al., 2004; Harmon et al., 2007; Slade, Lambert, Harmon, Smart,
& Bailey, 2008; Whipple et al., 2003). The CSTs were designed in order to improve the
outcomes of potential deteriorators and non-responders, since even with feedback, a substantial
percentage of these clients did not improve. The CSTs assessed for three domains when a client
was found to be deteriorating: therapeutic alliance, patient motivation, and social support
(Lambert et al., 2007). Once the client has taken this assessment, empirically- based decision
trees are created that help the therapist to know how to best adapt treatment in order to improve
the client’s outcomes. The results of these studies supported previous findings about feedback
interventions, and showed that the CSTs significantly improved results in terms of how many
clients deteriorated, how many reliably improved, and how many sessions deteriorating clients
stayed in treatment (Slade, et al., 2008).
In 2010, Lambert’s team undertook another meta-analysis in order to examine both the
effects of feedback alone, as well as the impact of the CST’s (Shimokawa et al., 2010). Their
analysis incorporated 6 studies, all of which had a feedback group, and four of which had a CST
group, although two studies did not have a control group. All studies were from Lambert’s team
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and incorporated scores on the OQ-45 as the criterion of outcome. The study performed the
analyses in two separate ways, one in which all clients were included (ITT method), and one in
which clients were excluded based on whether they were reasonably able to benefit from the
feedback intervention (i.e., attended more than one session of therapy) and called this the
efficacy method. They divided the groups into 4 major categories: treatment as usual, therapist
feedback, therapist and patient feedback, and CST (which included feedback). Each of these
groups had two subcategories, on track and not on track to improve. The results of this metaanalysis showed effect sizes ranging from .28 to .44 for the ITT method and between .53 and .70
for the efficacy method. This provided strong evidence for the utility of the signal alarm system
and the CST in preventing treatment failure. In examining the difference between the CST and
the regular feedback groups, there was a small difference (g=.16), indicating that there was likely
not much added benefit to the CSTs. The patient feedback was found to not improve outcomes
compared to therapist-only feedback. Compared to the previous meta-analysis, the results of this
study found similar effect sizes with the ITT method (which was used in the first meta-analysis),
but substantially larger effects with the efficacy method. Given that there was no need for the
signal alarm system to provide alerts at intake, it would seem that the efficacy method best
captures what the OQ-45’s capacity to improve outcome. This provides even more promising
evidence for the use of ROM in routine practice, although the authors caution that the efficacy
method substantially reduced the sample size due to the more stringent inclusion criteria.
There are, however, some limitations to Lambert’s research that should be acknowledged.
First, all of the research used to show the efficacy of the OQ-45 feedback and CSTs was
performed by Lambert and his team. This opens up the possibility of an allegiance effect, which
have been found to be common in both psychotherapy outcome studies (Luborsky et al., 1999)

64
and measure development studies (Blair, Marcus, & Boccaccini, 2008). Second, the OQ-45 was
the sole measure of outcome as well as the basis for the data in the feedback in every study. This
leaves open the possibility that the positive results of the RCTs may be influenced by a response
shift or a variety of alternate explanations that have yet to be ruled out (Evans, 2012). Third, all
but one study (Hawkins et al., 2004) in the meta-analysis were performed at the same university
counseling center, with the Hawkins et al. study accounting for a very small portion of the
overall sample size (n=306 out of n=6,151 total), potentially indicating a lack of generalizability.
Fourth, the factorial validity of the OQ-45 has recently come under criticism, as attempts to
replicate it have failed to identify discrete social roles and interpersonal relationship dimensions
and have found the correlation between the symptom distress and total score to be as high as .98
(Tarescavage & Ben-Porath, 2014). Despite these limitations, the work of Lambert and
colleagues has made a significant contribution in providing a foundation for the evidence base
for ROMs, helping them to gain increasing prominence in the field of psychotherapy.
Partners for Change Outcome Monitoring System (PCOMS). Another system that has
contributed to the evidence base for ROM is the PCOMS, developed by Scott Miller and Barry
Duncan (Miller, Duncan, Sorrell, & Brown, 2005). The PCOMS is based on two 4-item
measures, the Outcome Rating Scale (ORS; Miller, Duncan, Brown, Sparks, & Claud, 2003) and
the Session Rating Scale (SRS; Duncan et al., 2003). The ORS was designed to be a brief
alternative to the OQ-45, and as such, attempts to measure the same domains as the OQ-45 and
uses an ETR system modeled after Lambert’s signal alarm system (Miller, Duncan, Brown,
Sorrell, & Chalk, 2006; Miller et al. 2003). The SRS was developed in order to assess therapeutic
alliance based on Bordin’s (1979)’s definition, as well as a client’s theory of change. Both
measures are completed by the client and use visual analogue scales, with the ORS being
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administered prior to session, and the SRS being administered after each session. Similar to the
other ROMs discussed, PCOMS uses ETR and clinically significant change criteria to aid in the
interpretation of results.
Given the brevity of these measures, an essential task was to demonstrate that they
possess sufficient reliability and validity in order to be of value. Several studies have examined
the psychometric properties of the ORS (Bringhurst, Watson, Miller, & Duncan, 2006; Campbell
& Hemsley, 2009; Miller et al., 2003) and the SRS (Campbell & Hemsley, 2009; Duncan et al.,
2003). The ORS has been shown to have a Cronbach’s alpha coefficients between .85 and .95,
to be modestly stable over time (although test-retest reliability went as low as .49) and to have
modest to high correlations with existing measures (correlations between ORS and OQ-45
ranged from -.52 to -.74 across three studies). The SRS has demonstrated reliability, but has not
demonstrated as strong a correlation with existing measures of therapeutic alliance (Campbell &
Hemsley, 2009) as the ORS has with measures of distress. To date, there has been no factor
analysis performed on either of the PCOMS measures.
The PCOMS group has also performed several studies to examine whether the PCOMS
reporting system improves clinical outcomes (Anker, Duncan, & Sparks, 2009; Miller et al.,
2006; Reese, Duncan, Bohanske, Owen, & Minami, 2014). The first study (Miller et al., 2006)
was performed on a large sample (N=6424) of telephonic therapy clients at an employee
assistance program. This study used a quasi-experimental design in which they compared clients
treated using the PCOMS system with an archival baseline. They found that the PCOMS
improved outcomes substantially, with an effect size of.79 when comparing all clients and 1.06
with clients who began in the clinical range. These promising findings led to three RCTs that
employed a similar methodology to Lambert’s OQ-45 RCTs, in which the outcomes of the TAU
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group were compared with those who received feedback (Anker, Duncan, & Sparks, 2009;
Reese, Norsworthy, & Rowland, 2009; Reese, Toland, Slone, & Norsworthy, 2010). A major
strength of the PCOMS studies is that they were performed in a variety of treatment settings and
examined the utility of the PCOMS system in both couples therapy (Anker, Duncan, & Sparks,
2009; Reese, Toland, Slone, & Norsworthy, 2010) and individual therapy (Miller Duncan
Brown, Sorrell, & Chalk, 2006; Reese, Norsworthy, & Rowland, 2009). These studies found an
average effect size of .52 for feedback compared to TAU as well as improved retention rates and
higher usage rates by clinicians than other measures (Duncan, 2012). These results differ
somewhat from the OQ-45 research, where the feedback intervention was shown to be primarily
useful for those who were on track to deteriorate. Recently, a study was completed in which data
from a large behavioral health care practice used the PCOMS system for all clients for several
years and compared these scores to benchmarks established through RCTs on depression as well
as the feedback RCTs of the OQ-45 and PCOMS groups (Reese et al., 2014). They found that
the outcomes in their study were sufficiently similar to those of the depression RCTs to suggest
that the data was likely representative of the effects of treatment. From there, they examined the
OQ-45 and PCOMS feedback RCTs and found that their current study demonstrated similar
effect sizes to the OQ-45 studies (OQ: d=.57, current study:d=.71) but substantially less than
previous PCOMS studies (d=1.13). The effect sizes for the TAU benchmark were .46, indicating
that the current study improved outcomes by d=.25 relative to TAU, with the results of all
feedback research (OQ-45 & PCOMS) suggesting an increase due to feedback as d= .14 (total
effect size d=.60).
This study revealed a trend that the PCOMS system generally outperformed the OQ-45 in
improving client outcomes. There are several possible reasons for this. First, using a 4-item
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scale potentially narrows what is being measured and may be less stable over time. This seems
to be a possibility given that the test-retest reliability was relatively low and the concurrent
validity of the ORS with the OQ-45 revealed only modest correlations in two of the three
validations studies. Another possibility is that the sample size for the PCOMS RCTs were much
smaller (PCOMS= 408, OQ-45=4,268). This smaller sample size might increase the probability
of the results being sampling error, and thus not as reliable. Finally, the inclusion of the SRS to
assess the therapeutic alliance may have increased the efficacy of the feedback intervention in a
similar way to Lambert’s CSTs which showed increased benefit compared to feedback alone
(Reese et al., 2014). Although there are still questions to be answered, the PCOMS research has
strengthened the evidence base created by Lambert and colleagues, while showing that one can
achieve similar results to the OQ-45 in much fewer items (Duncan, 2012).
Using ROMs to evaluate therapist effectiveness. One of the major downfalls of the
EST movement was that its top-down approach to implementing best practices was not well
received. One alternative paradigm to this has been to examine whether specific therapists,
instead of treatment packages, are “empirically supported” (Bohart, 2000; Okiishi, Lambert,
Nielsen, & Ogles, 2003). This would provide a more bottom-up approach to EBP, as therapists
would be measured based on the results of their routine practice, instead of requiring them to
adhere exclusively to the results of RCTs performed in other settings. From this perspective, if
the therapist could show that their work was providing substantial benefits for clients, then there
would be no need to change what that practitioner does, even if they are not using an EST. If,
however, the clinician is not performing well, then interventions could be planned to help
improve the effectiveness of the therapist (Okiishi et al., 2006). In order to gather this sort of
data, it would require practice-friendly measures that are clinically relevant and could be
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administered frequently throughout the course of therapy. These requirements make ROM
systems an ideal candidate for the collection of such data, as they were designed to be
implemented in routine practice.
One of the first studies using ROM to examine the efficacy of therapists in routine
practice was performed by Okiishi and colleagues in 2003. This study examined the degree to
which 1,779 clients at a university counseling center changed (as measured by the OQ-45) in
response to the intervention of the 56 therapists at the center. What they found was that
therapists varied substantially in their outcomes, with the most effective therapist achieving an
average improvement in OQ scores of 20.77 points in 3.77 sessions (well over the RCI of 14),
and the least effective therapist’s clients deteriorating by an average of 5.75 points in 8.46
sessions. The authors also found that the therapists’ theoretical orientation, type of training,
amount of training, and gender did not significantly predict differential client growth trajectories.
These results provide evidence that therapists are performing at differential levels of efficacy,
and that these differences are not explained by the factors above. Thus, it would seem to be
more important to examine the reasons for differential efficacy of therapists, than to continue
doing studies attempting to empirically validate treatment packages. These findings also
highlight the importance of tracking outcomes in routine practice, as many clients may be getting
worse when they see certain therapists. The authors recommend several interventions for
improving the outcomes of the treatment center: (a) Show the results of the study to each
therapist and potentially explore the reasons for the results, (b) Refer clients to the most effective
therapists until their case loads are full and proceed in order of effectiveness and assign other
duties and additional training to less effective therapists.
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The same group sought to replicate their findings with a larger sample size, in order to
ensure the reliability of their results (Okiishi et al., 2006). Their follow-up examined the results
of 71 therapists who treated 6,499 clients at the same university counseling center across a period
of six years. In this study, more moderate differences were found between therapists, with the
top 10% of therapists seeing clients for 7.91 sessions, on average, leading to an improvement of
13.46 OQ-45 points, with the lowest ranking therapist seeing clients for more sessions (10.41)
leading to only an improvement of 5 points. This study also examined the rate at which clients
reliably improved, recovered (reliably improved and were below the clinical cutoff), did not
change, or deteriorated. Clients who saw a top 10% therapist had an average recovery rate of
22.40% (21.54% improved) and a deterioration rate of 5.20%. On the other hand, therapists in
the bottom 10% had a recovery rate of 10.61% (17.37% improved) and double the deterioration
rate of the top 10% (10.56%). In addition to differences in effectiveness, therapists were also
found to vary in efficiency (although the most effective therapists were not always the most
efficient) with the most efficient therapists (top 10%) achieving an average improvement of 1.59
OQ-45 points per session, and the least efficient therapists producing .4 points of improvement
per session. These results suggest substantial differences in therapist effectiveness and
efficiency, providing further evidence of the importance of routinely assessing the outcomes of
therapists and encouraging accountability in practice. In addition to the recommendations made
in the previous article, Okiishi and colleagues recommended making outcome information
available to clients to allow them to choose therapists. They discuss how the way to improve
treatment would be to identify what it is that makes effective therapists so effective, and build
this into training.
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Another approach was taken by the developers of the Treatment Outcome Package
(TOP). This group was concerned about the lack of complexity involved in evaluating the quality
of therapist outcomes. Their concern came in the context of budding governmental policies in
the USA in the early 1990’s that began to put pressure on therapists to provide evidence that, on
average, those who seek their services receive measurable benefit (Kraus & Castonguay, 2010).
The TOP developers’ primary concern was that policy-makers would attempt to judge the
outcomes of therapists based on narrow definitions that did not incorporate case mix variables
into their decisions. Thus, the developers created a measure that broadened the scope of the
outcomes measured, as well as incorporated complex case-mix algorithms that could portray a
more a nuanced picture of clinical outcomes (Kraus, Seligman, & Jordan, 2005). In their initial
validation study (Kraus et al., 2005), Kraus and colleagues factor analyzed a large data set from
383 different treatment sites and found that the TOP measured 11 factors. This stands in sharp
contrast to other ROM systems which often assess 3 to 5 areas, but generally report only one
total score in their studies of therapist efficacy, thus leading to unidimensional assessments of
therapist outcomes (Castonguay, Barkham, Lutz, & McAlveavy, 2013).
Using this multidimensional approach, Kraus and colleagues (2011), sought to examine
empirically the question of whether therapists demonstrate differential performance across the 11
dimensions (Kraus, Costinguay, Boswell, Nordberg, & Hayes, 2011). This study included the
TOP data for 6960 patients who were seen by 696 therapists (10 patients per therapist). The
authors defined effectiveness as having the average client experience reliable change in a
specific dimension. Thus, if a therapists’ mean client change was in the positive direction they
were labeled “effective” in that dimension, if the average change was negative, then they were
labeled “harmful” and if there was no change, they were labeled “unclassifiable.” Using these
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criteria, the study found that therapists, on average, were effective in 5 TOP domains, with 96%
of therapists identified as effective in at least one domain and no therapist was competent in all
domains (although the “mania” scale showed very little change). Therapists were then ranked
within each dimension in terms of their effectiveness, and it was found that the correlations
between rankings in any given domain did not exceed .33. This finding provides support for the
idea that competence in one area does not necessarily translate to other areas of functioning.
The authors discuss how these findings have many implications such as potentially matching
clients with providers who have a demonstrated track record at working effectively with the
clients presenting concerns, as well as having therapists use the results to identify areas of
strength and weakness that can be targeting for further training. These findings also offer a
critical view toward the studies performed by Okiishi and colleagues using the OQ-45. Given
the finding that most therapists were effective in at least one domain suggests that a binary
categorization of therapists into ‘effective’ and ‘ineffective’ groups based on a single criterion
may be misleading.
A substantial limitation of this study, however, is the sample size. Given that there were
11 TOP domains and only 10 clients per therapist, it would not be unlikely that therapists might
not see any clients that have problems in specific TOP dimensions. Thus, their results in any
given dimension could be based on one client that had concerns in that area. On the other hand,
the large size of their overall sample, and the substantial number of therapists involved in the
study could account for this problem.
Overall, the research investigating differential therapist efficacy provides strong support
for the value of ROM in improving outcomes at the individual client level, as well as facilitating
research that can help therapists and treatment sites to gain a clearer sense of their strengths and
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weaknesses. It also shows how ROM could be used to examine questions of why therapists may
be more effective, which could drastically change therapist training protocols.
Lack of Usage of ROM
Despite the strong body of research supporting the usage of ROM, it has not achieved
widespread implementation in routine clinical practice. In order to examine usage rates of
outcome measures in routine practice, Phelps and colleagues (1998) gave a 9-item survey to a
large sample (n=15,918) of American Psychological Association (APA) members who were
identified as direct psychotherapy providers. The authors reported that 24% of Independent
practitioners and 40% of medical facilities used outcome measures in their practice, suggesting
substantial variability across the types of practices. The authors examined a subset (n=1600) of
the sample’s answers to a free-response item about whether they use outcome measures in their
practice, and if so, the names of the measures. They found that approximately 22% of clinicians
used some sort of standardized outcome measure, with the most used measure being the Beck
Depression Inventory (n=95, 6% of total). Others reported using unstandardized patient report
(8%) or informal clinician report (5%), while 66% (n=1,049) of the sample reported using no
outcome measure. Their study suggested that only a minority of practitioners were using
standardized assessments in their clinics. Most ROM systems, however, were still relatively new
or not yet developed at the time this article was published, but it does provide some context into
the lack of value given to standardized assessments by clinicians, especially those not in a
medical setting.
In 2004, Hatfield and Ogles performed a survey using similar sampling procedures as
Phelps, Eisman and Kohout (1998) in order to examine the usage rates of standardized
assessments. Their sample consisted of 874 practitioners from a variety of settings, with
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substantial representation from solo private practitioners (46%). They found that 37% of
respondents reported using an outcome measure in their practice, although of this group (n=324),
12% endorsed not using a standardized outcome measure. Thus, 32% of the clinicians in their
study used a standardized outcome measure in their practice, with the Beck Depression inventory
being the most used standardized measure (n=146, 45.3% of standardized measure users). The
only ROM system with enough users to be reported in the study was Lambert’s OQ-45 with 18
clinicians (2.1% of the total sample) using it in their practice. It is possible that there were some
that fit in the “Other” category, but these would represent very small percentages. They also
found that cognitive or behaviorally oriented therapists were more likely to use outcome
measures than insight-oriented therapists. Thus, although Hatfield and Ogles’ study found that
approximately one-third of clinicians use some sort of outcome assessment, about 98% of
clinicians reported not using ROM systems.
Clinician attitudes towards ROM. Given the lack of usage of ROM systems, there has
been an interest in understanding why these measures are not being used. With this in mind,
several studies surveyed or interviewed clinicians in order to gain greater insight into their
reasons for not using ROM systems. In 1999, Abrahamson examined the implementation
process of an outcome measure in routine practice. He reported three major reasons which
deterred clinicians from using ROM systems: (a) concerns about performance being measured,
(b) logistical considerations (i.e., time burden), and (c) conceptual appropriateness of the
measure. The author discussed how logistical details must be worked out meticulously, and that
those who are expected to use the measures should have substantial input into what is assessed.
These themes are present throughout the literature from the time of Abrahamson’s study to more
recent studies and will be explored in greater depth as the literature is discussed.
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Garland, Kruse, and Aarons (2003) examined clinician attitudes in a large children’s
public mental health service system in California. At this time, the state government had
mandated the use of an outcome assessment battery that was to be routinely administered, with
results being sent to the state government. The authors sought to examine clinician attitudes
toward the use of the measures with individual clients. The sample consisted of 50 clinicians
with varying years of experience, with the majority being master’s level therapists (62%). In
order to examine clinician attitudes, the authors developed a semi-structured interview that was
administered to clinicians either in a focus group or individually. These interviews were
recorded and then coded to identify major themes. They found that 25% of clinicians expressed
strong ideological opposition to the idea of a quantitative outcome measure, while another 25%
were skeptical about the ability of these measures to assess therapeutic change. “A few
respondents” (p.398) endorsed strong support for the use of the outcome measures, while many
expressed ambivalence. Additionally, they found that, on average, clinicians rated standardized
measures and scales as the least important method of evaluating effectiveness, with functional
indicators being rated the highest (school grades, disciplinary actions etc.). Most clinicians
reported that they did not feel increased pressure to demonstrate their effectiveness with the use
of outcome measures, which offers a contrast to Abrahamson’s (1999) fear of evaluation
concern. Most attributed this to the perception that the data was not even being used, so the
perceived unlikelihood of evaluation may explain why the clinicians in this sample did not
experience this fear.
The authors categorized clinician barriers into 3 categories: (a) feasibility concerns, (b)
perceived invalidity, and (c) interpretation difficulties. The first two categories are also
represented in Abrahamson’s (1999) study, but the third was unique to this study. Almost all
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respondents (90%) felt that there was a substantial time burden associated with the measures,
with most expressing frustration at having to do administer and take the measures. Some also
reported having received negative feedback from parents about filling out the measures, with few
providing positive feedback. About 55% believed that the measures were not relevant to their
clients, or that it did not fit well with their theoretical orientation. Participants stated that the
reports were difficult to use and did not provide much useful information. Several clinicians
reported that they would have liked to have been involved in the selection of the constructs being
measured.
In regards to their use of the scores/reports, 92% indicated that they had never used them
in their clinical practice, which was tempered somewhat by over half (60%) of the respondents
making comments about how the process of administering the measures was helpful in and of
itself. The clinicians talked about how it was helpful to be able to see what parents thought
about their children’s problem and often gave openings for discussing topics with parents that
would not have been explored otherwise. These findings are in line with other studies that have
considered the role of ROM feedback in enhancing the communication between therapist and
client (Halstead, Yuon, & Armijo, 2013; Reese, Slone, & Miserocchi, 2013).
This study highlights the varying opinions of clinicians regarding ROM, and that the
current offerings seem geared toward clinicians with certain philosophies of therapy. Despite
these somewhat disappointing findings, the authors found that the overwhelming majority of
clinicians in their sample were interested in assessing outcome in some way, even though they
found the current measures lacking.
In 2006, Meehan, McCombes, Hatzipetrou, and Catchpoole sought to explore clinician
reactions to the introduction of ROM and the utility of outcomes data in their practice. Their
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study utilized a focus group methodology, in which 324 practitioners from a variety of settings
were interviewed in 34 group discussions. Similar to previous studies, the authors found that the
clinicians had mixed opinions about ROM. They reported that “even those in favour of outcome
measurement questioned the validity of the measures and felt the selected measures were too
brief and broad to be useful” (p. 583).
The participants discussed the difficulties of balancing relevance with practicality, in that
if the measures were more comprehensive, they would become too long to be feasible for routine
practice. This highlights a common difficulty with ROM systems: how to create a measure that
is sufficiently brief to be practical for routine use, while still providing sufficient breadth to be of
clinical value (Slade, 2002). Additionally, some participants reported feeling that the measures
were overly reductionistic, and offered little insight into the worldview of the client. The
authors’ interpretation of these concerns was that they “highlighted a lack of understanding of
the measures” (p. 583). When the authors asked which measures would be more appropriate, the
clinicians were unable to reach a consensus, as each suggested measure was critiqued. From
this, the authors concluded that consensus was very difficult to achieve, and that the clinicians
likely could not be pleased. The authors also found that participants reported some trepidation
about how the outcome data would be interpreted. Given that this study was performed in
Australia, where ROM was required by the government, the data from the outcome measures
could be used to evaluate the efficacy of their treatment, despite them feeling that is does not
capture the scope of their work. Finally, concerns about time burden were present. There were
measures that the therapists needed to complete, or client measures that they needed to enter into
the system, and these often required the clinicians to wait in line for a computer to enter the

77
scores. This study confirms all three of Abrahamson’s clinician concerns but provided a more
“thick” description of what types of concerns clinicians had about ROM systems.
In a follow-up to their 2004 article, Hatfield and Ogles (2007) performed a study in
which they sought to examine reasons why therapists use or do not use outcome measures. The
same database as their 2004 study was used, but different analyses were performed. In terms of
why clinicians do not use outcome measures, their primary finding was that practical concerns
such as time burden and lack of resources was the strongest reason. Additionally, they found
that the second most common reason was perceived lack of utility, in that practitioners did not
feel it was helpful or potentially distorted the effects of treatment. These reasons are closely
aligned with those documented in the studies examined thus far, and suggest that practicality and
relevance or clinical utility are the two most prominent reasons that clinicians do not use
outcome measures.
Support for clinician attitudes. In the ROM literature, few would disagree that
practical/logistical difficulties are a legitimate barrier to implementation, and that work needs to
be done to improve this area (Boswell et al., 2015). The concern about relevance, however, has
been more controversial. As documented in the previous section, many clinicians report
perceiving the measures as not relevant to their work, but ROM developers have expressed
disagreement to these claims. (Boswell et al., 2015; Meehan et al., 2006). The next sections will
explore this issue from both perspectives.
Some researchers have attempted to examine whether the clinician perception that the
measures are not relevant is a valid concern. Ashworth & colleagues (2007) sought to answer the
question of whether the CORE-OM, a prominent ROM system, was addressing the majority of
concerns that clients brought in to treatment. This was accomplished by comparing the items
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generated by clients on an idiographic measure, through thematic analysis, and examining
whether these areas were assessed by the CORE-OM. The idiographic instrument used, was the
Psychological Outcome Profiles (PSYCHLOPS), which was developed by Ashworth’s research
team (Ashworth et al., 2004). The sample was composed of 215 clients currently in
psychotherapeutic treatment. The authors examined all client-generated items and grouped them
into 8 main themes and 61 subthemes. In examining the sub-themes they found that 27 (44%)
were not present in the CORE-OM. Additionally, 60% of clients reported at least one presenting
concern that did not map onto any CORE-OM item. This suggests that the CORE-OM did not
assess at least one major concern for the majority of clients in the sample, and did not account
for nearly half of the types of concerns that clients brought to therapy. These results provide
support for clinician claims that ROM systems may not be valid to the populations that they
serve.
In addition to Ashworth and colleagues’ study (2007), some authors have presented
theoretical arguments about how ROM systems, as currently constituted, lack relevance. Chris
Evans, one of the developers of the CORE-OM, wrote an article in which he advocated
exercising caution in the use of ROM systems (Evans, 2012). Evans discusses how ROM
systems were generally built using a nomothetic approach to measurement, in which the purpose
was to assess constructs at a broad level and to make the measures equally applicable across
multiple populations. Additionally, the measures were designed to be administered on a sessionby-session basis, thus requiring them to be much more brief than traditional cross-sectional
assessments. In doing so, he states that “we cannot escape the fact that we have traded out
exploration of certain areas of positive or negative experience, particularly ones relating to
interpersonal functioning and risk, in order to get coverage across as many clients as possible”
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(p. 133). He describes how the measures generally perform well in measuring areas of
intrapersonal concerns (i.e., depression and general well-being), but that they are less able to
assess interpersonal concerns in a way that is applicable to most people, because people are
involved in different types of relationships (intimate, occupational, nuclear family, etc.). This
sounds quite similar to many of the concerns that clinicians brought up about the scope of
measurement, and raises the question of whether this trade-off of global applicability for
specificity is worth the cost.
His views are corroborated by the relatively weak psychometric properties of scales
assessing interpersonal concerns in ROM systems. The OQ-45’s interpersonal relations scale
was reported to have a Cronbach’s alpha of .74, and the TOP’s Social Conflict scale was
reported to have an alpha of .72. These reliabilities are much lower than what was found for the
OQ-45’s symptom distress scale (.92) and the TOP’S Depression scale (.93). Additionally,
although some moderate and large correlations with relationship-oriented criterion measures
were found, in most cases the same criterion measures correlated more highly with intrapersonal
scales, suggesting a lack of discriminant validity. These properties are not wholly unacceptable,
but are much weaker than those found in the intrapersonal scales of these same measures.
Similar patterns were found with scales of occupational functioning in these measures, except
that no large correlations were found with a criterion measure (Kraus et al., 2005; Lambert et al.,
1996). With these considerations, Evans concludes that the philosophy that guides the
development of ROM measures is geared toward “producing useful lowest common
denominators that will give precision at low cost… it is not about producing high quality, high
precision, adaptable measurement of individual change” (p.133).
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Given this approach, Evans worries that a focus on outcomes generated by ROM
systems, could lead to therapists to focus on attempting to improve the areas that are assessed by
the measures, at the expense of more subtle or difficult topics. Thus, although ROM developers
generally advise that the results of the measure be contextualized to the individual circumstances
of the clients, it is possible that therapists may try to adapt what they see in treatment to fit the
results of the measure. He expresses especial concern about this issue with trainees, in that if the
client is within expected treatment response range, the student therapist may not be as attentive
to the possible need to address more sensitive topics. Instead, the measure could serve an
analgesic function, alleviating the anxiety of the trainee because the score on the measure is
improving, while the client may be struggling in areas not assessed by the measure. Overall,
Evans’s treatise provides a more elaborate explanation of some of the possible therapist concerns
regarding the relevance of the measures. Combined with Ashworth and colleagues’ work, it
shows that at the very least, clinician concerns should be acknowledged, and critical dialogue
should be had about the philosophy underlying the development of these systems as well as the
areas they assess.
Researcher conceptualizations of lack of usage. In early 2015, as part of a special
issue of Psychotherapy Research about practice-based evidence, the authors of three of the major
ROM systems in the United States came together to discuss what they perceived as the major
barriers to ROM implementation (Boswell, Kraus, Miller, & Lambert, 2015). In line with
previous research, they identified two major obstacles: practical and philosophical. In terms of
practical obstacles, financial burden, time burden, and multiple stakeholders with different needs
were identified. They discuss several areas where clinician and client time can be used, and
emphasized the importance of creating software that can streamline the process of administering
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and scoring the assessments. Additionally, they cite difficulties with making a system that is
appealing to the various stakeholders involved in the therapeutic process, and how if
stakeholders do not feel their needs are met, the initiative will likely fail.
As the authors begin to discuss “philosophical obstacles,” the tone of the article shifts. In
discussing concerns of a practical/logistical nature, the authors emphasized making sure that the
measure fits well with the context of local treatment sites, and were careful not to dismiss
clinician concerns. In contrast, the “philosophical obstacles” section leads off by discussing how
clinician’s concerns about relevance are the result of irrational expectations that the ROM
systems should be “perfectly reliable, valid, appropriate and sufficient (i.e., relevant) for each
individual client” (p. 6). The almost defensive tone in this section, in which the authors
exaggerate the clinician concerns about relevance by suggesting that they want the measures to
be perfect, immediately dismisses the concerns about relevance as being the result of erroneous
perceptions. The authors then proceed to attempt to educate the clinicians on how the measures
should be used, and discuss that these limitations to relevance are inherent to all measures. This
way of addressing concerns about the relevance of ROM systems exonerates the properties of the
measures from responsibility for the lack of implementation, and places this responsibility on the
biases of the clinicians.
Later in the article, the authors briefly mention how they are consistently improving the
psychometric properties and predictive algorithms of the measures, and that this addresses the
issue of relevance. The authors, however, provide no specific information about how this would
be done, or how it would address concerns about relevance. The assumption is that if the
psychometric properties and prediction algorithms are improved, then clinicians will find it
useful and relevant to their clients. It does not address, however, the concern that the measures
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are missing important outcomes for specific clients, or that their scope is too global to be of
value to clinicians (Evans, 2012). Up to this point, no ROM systems have had their item pool
changed after their initial validation studies, thus it is unlikely that this is what is meant by
improving psychometric properties.
Additionally, the authors stated that “therapists’ confidence in their clinical judgment
alone stands as a barrier to implementation of monitoring and feedback systems” (p. 8). The
question that arises from this statement is why clinicians would rely only on clinical judgment
when tools such as ROM systems are available. Walfish, McAlister, O’Donnel, and Lambert
(2012) attribute this to therapist self-assessment bias. In this study, the authors examined
whether therapists have an overly positive bias toward their abilities. They found that clinicians
generally rated themselves as above average (mean rating: 80th percentile), which the authors
viewed as a statistical impossibility. Additionally, nearly two thirds of the sample believed that
80% or more of their clients improved by receiving therapy from them, and that only 3.66% of
their clients deteriorate. The authors contrasted this with research that suggested much lower
rates of improvement and higher rates of deterioration for the average therapist, such as the work
by Lambert’s group’s studies about therapist effects (Okiishi, Lambert, Nielsen, & Ogles, 2003;
Okiishi et al., 2006). Based on this data, the authors conclude that therapists view their
capabilities as greater than they are, and that this suggests a biased self-assessment. The authors
then state that “therapist self-assessment bias may be at the root of therapists’ reluctance to take
advantage of advances in ‘lab test’ results [ROM]” (Walfish et al., 2012; p.5). Therefore, the
reason that clinicians trust their clinical judgment alone is because they have a cognitive bias that
leads them to think that they are better than they are, and that they do not need ROM. These
results lead to the conclusion that the primary reason for a lack of implementation of ROM is not
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a lack of relevance or practicality of the measures, but due to erroneous clinician attitudes that
are detrimental to clients.
The rationale just discussed is one of the predominant researcher narratives about the lack
of ROM usage, however others exist. Some claim that “most of the ‘restraining factors’ emanate
from underlying performance anxiety on the part of clinicians” (Mellor-Clark, Cross,
Macdonald, & Skjulsvik, 2014, p.4) or from a lack of understanding of the scope of ROM
measures or of measurement theory (Boswell et al., 2015; Meehan et al., 2006). What all of
these attributions have in common is that they view the lack of success in implementing ROM
systems as being due to problematic characteristics of clinicians, and not the shortcomings of the
measure. Thus, clinicians’ concerns about relevance are not really about the validity of the
measure to their local context, but about clinician’s attempts to maintain a positive view of their
work or to avoid experiencing anxiety related to their performance. From the perspective of
ROM proponents, the clear implication of this is that actions need to be performed in order to
change clinician attitudes. Additionally, they need to help correct erroneous clinician
perceptions through training and education, in order to convince clinicians that ROM aligns with
their personal and professional goals (Boswell et al., 2015; de Jong, 2014; Lakeman, 2004;
Willis, Dean, & Coombs, 2009).
The fact that researchers attempt to frame the lack of clinician acceptance of ROM as
involving some sort of problem with the clinicians’ attitudes is not surprising given a growing
body of literature in the management literature that questions traditional conceptions of
resistance. Ford, Ford, and D’Amelio (2008) discuss how in accounts of attempts to implement
change, that “resistance is portrayed as an unwarranted and detrimental response residing
completely ‘over there, in them’ (the change recipients)” (p.362). The authors describe how this
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narrative is often self-serving for the change agents, in that it provides an account for the lack of
implementation of the change, without implicating the change agent or their product.
Additionally it “shift[s] responsibility for resistance from things under their control (i.e.,
systemic factors) to the characteristics and attributes of recipients” (p.365). This approach is
evident in ROM proponents’ views that clinician concerns about relevance are not to be taken as
feedback that needs to be accommodated by the measure, but an attempt to wrongly discredit the
measures in order to preserve their self-image. The vast majority of researcher accounts about
the lack of usage of ROM suggest, either explicitly or implicitly, dismiss the possibility that
clinicians may not use the measures because the measures need to be changed or adapted
because they are not relevant or practical for clinical needs (Boswell et al., 2015; Mellor-Clark et
al., 2014). Until these views are changed, it is likely that implementation approaches will
continue to be focused on correcting clinician cognitive biases, while clinicians focus on the
shortcomings of the measures. This situation is unlikely to lead to productive dialogue, as it is
possible that both view the other as threatening or at least misguided, and are unwilling to
compromise and negotiate.
This leads to a crucial issue, are the clinician concerns about relevance only based on
erroneous presuppositions or are they in fact legitimate concerns, or are they some combination
of the two? As has been discussed above, both parties appear to have evidence for their position,
and will use this against each other, so the answer is not clear cut. If ROM developers simply
change clinician attitudes, will the field be losing something of value that could potentially
improve the way ROM is done (Evans, 2012; Ford et al., 2008)? On the other hand, if ROM
systems as currently constituted are rejected, and ROM developers attitudes changed, would
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something of value be lost as well? The answer to these questions could have major implications
for how ROMs are developed and implemented.
If the clinicians who claim that the measures are not relevant to their context are correct,
then it should follow that ROM systems should be built that focus on adapting the measure itself
to the needs of specific treatment sites, therapists, and clients. These types of accommodations,
however, are not possible in current ROM systems, because they were built on the assumption
that brief, standardized, and broadly applicable assessments are preferable to more individualized
measures. It would be neither feasible nor desirable to have the measures adapt to each
treatment site, therapist, and client. On the other hand, if the clinicians’ skepticism is in fact just
the result of self-assessment bias, a lack of understanding of the measures, or based on
performance anxiety, then these clinician perspectives are potentially hurting their clients and
efforts should be undertaken to help correct practitioner biases. In this case, there would be no
need to change existing measures nor the paradigm on which the measures rest and
implementation should continue its current course. Unfortunately, these competing views lead to
a deadlock between ROM developers and clinicians, which is likely to continue to lead to
researchers being frustrated at clinician cognitive biases, and clinicians feeling that researchers
are forcing an irrelevant bureaucratic task on them, that could potentially harm their clients.
A New Implementation Approach
Thomas and Hardy (2011) advocate for a different approach to implementation. In this
article they discuss how the approach of “demonizing” and thus attempting to overcome ‘change
recipient’ resistance to change has not proven effective (Beer & Nohria, 2000). They argue that
“while change can be imposed, it is more likely to be taken on by members of the organization if
they have played a part in the negotiations of new meanings, practices, and relationships”
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(p.323). In this framework, traditional distinctions of change agents and change recipients are
broken down, with both sides at times playing the part of agent and recipient of change. This
facilitates a process in which negotiations can occur that will allow for emerging ideas that
develop between the participants, and that are acceptable to both. With this conceptualization of
change, implementing ROM systems changes from a question of “who resists organizational
change, why and when, to a question of how relations of power and resistance operate together
in producing change and in what ways” (p.326). From this perspective, clinicians’ reluctance to
embrace ROM could be seen as “resistance,” but so could ROM developers’ dismissive attitude
toward clinician concerns about relevance. Thus, the implementation process does not assume a
correct answer from the outset (i.e., Clinicians need to implement ROMs, or ROMs are
completely irrelevant to therapy), but focuses on dialogue between the two parties, in order to
create shared meaning. It is hoped that this perspective will allow the merits of the current
approach to ROM be available for discussion, and for the voices of key stakeholders to be
valued.
In order for such an approach to be realized in ROM implementation, however, there
must be room for negotiation from both researchers and clinicians. Unfortunately, existing ROM
systems are not designed to accommodate local input, as items are chosen primarily on the basis
of psychometric considerations and the opinions of clinicians involved in the initial development
of the measures. This is required in order to ensure comparability between clients, to create
norms (i.e., clinical cutoffs), as well as generate ETR curves. In order for more productive
relationships to develop between ROM developers and clinicians, a new paradigm of ROM
development is required that allows for negotiations of the meaning of outcome while still
maintaining some degree of standardization. To this point, no such system exists.
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